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THE ROLE OF THE RETICULOENDOTHELIAL SYSTEM 
IN THE INDUCTION OF IMMUNE TOLERANCE
CHAPTER I
INTRODUCTION AND LITERATURE REVIEW
Origin of the Theory of Phagocytosis 
The theory of phagocytosis was born on the shores of the 
Mediterranean in Messina in 1882. It was there that the brilliant 
Russian zoologist, Elie Metchnikoff, observed that if he inserted a rose 
thorn under the skin of a starfish larva, mobile cells of the larva soon
migrated to the intruding particle and surrounded it (Metchnikoff,
1907). He suggested the term phagocyte, from the Greek translation of 
"devouring cells," to describe these mobile cells capable of ingesting 
foreign materials. Metchnikoff devoted the next 25 years of his life 
to developing his phagocytic theory and delineating its role in host de­
fense to infectious diseases. The essential role of phagocytic cells in
host resistance to disease remains undisputed today.
The Concept of the Reticuloendothelial System 
Aschoff (1924) advanced the concept that phagocytic cells con­
stituted a physiological system. This theory was based primarily upon 
the functional property of these cells of ingesting various vital dyes
or other particulate material, rather than upon cyotological criteria.
1
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Aschoff proposed the term, reticuloendothelial, to describe this system 
of phagocytic cells after observing them as components of both the re­
ticular and endothelial tissues of various organs.
The cells of the reticuloendothelial system (RES) fall into two 
main anatomical categories, as depicted in Figure 1 (Aschoff, 1924).
The sessile macrophages are cells of the reticular network of the spleen, 
lymphoid tissue and thymus, and the endothelial cells lining the sinus­
oids of the liver (Kupffer cells), spleen, lymphoid tissues and bone 
marrow and the capillaries of the adrenal and pituitary glands. These 
cells are fixed in strategic locations so that they may pick up particles 
carried to them by the blood and lymph. Also included in the RES are 
the wandering macrophages (histiocytes or clasmatocytes) found in connec­
tive tissue throughout the body and in the blood.
Baillif (1956) believes the corpus luteum of the ovary should 
be included in the RES as it contains sinusoids lined with actively 
phagocytic cells. The microglial cells of the central nervous system 
have also been considered as elements of the RES but some disagreement 
exists as to the validity of their inclusion (Arteta, 1956).
Measurement of RES Activity by the Carbon 
Clearance Technique
A classic method of studying the function of a given system has 
been to surgically remove it from the organism and note the resultant 
physiological alterations. In some cases it has been possible to main­
tain the excised system by artificial means and study the effect of vari­
ous treatments upon its function. The diffuse anatomical nature of the 
RES has prohibited its study by these methods. However, the ability of
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Figure 1— Cellular constituents of the reticuloendothelial system.
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RE cells to phagocytize foreign materials has led to the development of 
in vivo methods to evaluate quantitatively RES activity in certain organs. 
A large number of RE cells are found in the liver (Kupffer cells) and 
spleen (reticular cells). Since these cells are in contact with the 
blood, it is possible to measure their phagocytic activity by determin­
ing the intravascular clearance rate of various materials such as dyes 
and colloidal suspensions. Many of the early attempts to evaluate RES 
activity failed because the materials employed were cytotoxic, impure or 
had other undesirable qualities. Benacerraf, ^  al• (1957) and Neukomm, 
et al. (1957) have outlined the criteria which should be fulfilled by 
substances utilized in the measurement of phagocytosis.
In recent years, the use of a colloidal suspension of carbon has 
found favor with many investigators. Halpern, e^ (1953) were among 
the first to use colloidal carbon to study RES function although Fenn 
(1921a, 1921b) used it to quantitate the phagocytic activity of leuco­
cytes. The first carbon suspensions employed were found to be toxic to 
rats at dosages exceeding 16 mg carbon/100 gm body weight. The toxicity 
was due to shellac which had been added to the suspension as a stabilizer 
(Halpern, £t , 1953). The shellac caused a release of thromboplastin 
which depleted the blood of its anticoagulatns resulting in coagulation 
of fibrin in the circulating blood. Subsequently, a carbon suspension 
in fish glue, free of shellac, with a small amount of phenol added as a 
preservative, was found to be non-toxic in doses as high as 64 mg 
carbon/100 gm body weight (Benacerraf, e^ a]̂ ., 1954; Biozzi, et al.,
1953) and this preparation is now used routinely in RES studies employ­
ing the carbon clearance technique.
5
Biozzi, ^  (1953) and Benacerraf, e^ (1957) studied, in
considerable depth, the kinetics of carbon clearance by the RES in a 
variety of laboratory animals. They found that the rate of clearance of
carbon from the blood was an exponential function of time and could be
log Cn - log C -KTexpressed by the equation, ----- -------  = K or C = C^IO , where
is the concentration of carbon in the blood immediately after injection
and C is the concentration at time T. The constant, K, is a measure of
the rate of clearance and is termed the phagocytic index. This index
varies inversely with the dose of carbon administered.
RES activity was found to be greatest in the mouse, lower in 
the rat, still lower in the guinea pig and least in the rabbit. This 
was explained by the difference in relative size of the,livers and 
spleens, the organs which account for 90-95 percent of the phagocytic 
activity of the RES. The smaller animals have relatively larger organs 
and, hence, greater phagocytic activity. When the corrected phagocytic 
index, a, was calculated from the equation, a = where W/Wls is
the ratio of body weight to liver and spleen weight, the values were 
quite similar for all animals.
The carbon clearance technique is well standardized, convenient 
and inexpensive. It has, therefore, been used extensively to investigate 
the effect of a wide variety of substances, as well as physiological and 
environmental conditions, on RES function.
RES Depression by Certain Lipids
The alkyl esters of several simple fatty acids have been found 
to exert a profound depressive effect on RES phagocytic activity as de­
termined by the intravascular clearance of colloidal carbon.
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Ethyl Stearate
Inhibition of normal RES function by intravenous injection of 
the ethyl ester of stearic acid was initially demonstrated by Stuart, 
et al. (1960). Maximum RES depression in the mice was noted 24 hours 
after lipid administration with a return to normal function occurring 
in 3-4 days. Liver and spleen weights were not significatnly altered 
during this time interval. The duration of RES depression could be ex­
tended for some time by repeated injections of lipid. More detailed 
studies were subsequently made by Stuart and Cooper (1962) on the effect 
of ethyl stearate in mice. A dose-response effect was seen. A 10 mg 
dose was not effective but doses of 20 mg and 30 mg produced a three­
fold decrease in phagocytic activity and 40 mg resulted in maximum im­
pairment of RES activity. Larger doses were not studied due to their 
toxicity.
When given, intravenously, ethyl stearate exerts its effect pri­
marily on the sessile intravascular phagocytes (Stuart and Cooper, 1962). 
Histologic studies after ethyl stearate treatment revealed a decrease in 
the number of splenic and hepatic macrophages containing carbon. This 
could be interpreted as a decrease in the total number of phagocytic 
cells or as an impairment of their functional capacity. The former in­
terpretation is supported by electron microscopic studies which demon­
strated that Kupffer cells are sometimes severely damaged following 
ethyl stearate treatment. Thus, it would appear that ethyl stearate 
exerts its depressive effect on the RES through a direct or indirect 
cytotoxic mechanism. A similar cytotoxic effect on lymph nodes was 
noted by Shivas and Fraser (1959) following intraperitoneal injection of
7
this material.
Phagocytic stimulants, such as triolein and bacterial lipopoly- 
saccharide, have been found to confer some degree of protection upon 
mice against infection with Diplococcus pneumoniae. Ethyl stearate re­
versed the RES stimulating and protective effects of these materials 
(Cooper and Stuart, 1961, 1962).
Cholesterol Oleate
The effect of a sterol ester, cholesterol oleate, on RES func­
tion was investigated by Stuart (1962) and Stuart and Davidson (1963). 
Little change in phagocytic function occurred with a 10 mg dose. How­
ever, marked depression lasting for 2-3 days was produced by a 30 mg dose. 
After a 50 mg dose spleens appeared granular, enlarged and tomato pink 
in color. The splenic lymphoid follicles were intact but the red pulp 
was fatty and of poor phagocytic quality. Focal necrosis of the liver 
was also observed (Stuart, 1962). The growth of mice treated with 90 mg 
of cholesterol oleate was arrested. Liver and spleen weight were in­
creased and these organs contained large amounts of the ester, suggest­
ing physical saturation of the RE cells as the mechanism of phagocytic 
depression (Stuart and Davidson, 1963).
Ethyl Palmitate
Ethyl palmitate is an efficient inhibitor of RES phagocytosis 
as measured by intravascular clearance of colloidal carbon (Stuart, 1960) 
and human red blood cells (Buchanan and MacGregor, 1964). Early studies 
in mice by Stuart (1960) revealed widespread splenic destruction, but 
only a minor amount of liver necrosis, following a single intravenous
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injection of 25 mg of lipid. Smaller doses inhibited phagocytic activity 
without observable splenic necrosis. More recent studies by Prosnitz,
£t (1969) have confirmed Stuart's findings. Single intravenous in­
jections of this ester into mice resulted in a selective and acute 
splenic necrosis, maximal at 24-72 hours, with regeneration evident in 
7-10 days. Within 1 hour after injection both the liver and spleen were 
extensively infiltrated with fat. Within the next hour, nearly all of 
the lipid had disappeared from the liver, indicating that ethyl palmitate 
was rapidly metabolized by this organ.
Repeated injections of ethyl palmitate effected a complete and 
permanent destruction of the spleen (chemical splenectomy) in most mice, 
rats and rabbits. Some species, however, reacted differently to ethyl 
palmitate, e.g., splenic necrosis in guinea pigs was only moderate com­
pared to that seen in mice. Further, random bred Swiss mice had some­
what more marked liver damage and only minimal splenic necrosis 
(Prosnitz, et al., 1969).
Methyl Palmitate
Wooles and DiLuzio (1963) reported a selective depression of 
RES function following treatment with methyl palmitate. As with other 
lipid RES depressants, methyl palmitate was effective only when admini­
stered by the intravenous route (DiLuzio and Blickens, 1966). The most 
profound impairment of phagocytosis occurred with a dose of 35 mg per 
mouse although doses ranging from 15-40 mg were also effective. RES 
depression was evident within 5 hours after lipid injection and increased 
to a maximum at 48 hours. Phagocytic activity remained depressed for 7 
days after methyl palmitate administration. Normal function was regained
9
in 12-17 days.
The mechanism by which methyl palmitate impairs RES function 
has been studied extensively (Wooles and DiLuzio, 1963; DiLuzio and 
Riggi, 1964; DiLuzio and Wooles, 1964; Blickens and DiLuzio, 1965; DiLuzio 
and Blickens, 1966; Saba and DiLuzio, 1968). Nevertheless, although some 
information is available, the exact mechanism remains uncertain. In con­
trast to the cytotoxic effects of ethyl stearate (Stuart and Cooper,
1960), ethyl palmitate (Stuart, 1960) and cholesterol oleate (Stuart,
1962), methyl palmitate did not cause any observable damage to either 
splenic or hepatic cellular elements. Further histological studies re­
vealed a marked decrease in the hepatic uptake of colloidal carbon.
DiLuzio and Riggi (1964) observed a similar depression in the splenic 
and hepatic uptake of an "RE test lipid emulsion" following methyl pal­
mitate administration. These findings, together with the fact that 
methyl palmitate did not alter hepatic parenchymal cell activity, led 
DiLuzio and Wooles (1964) to suggest that this lipid exerts its effect 
exclusively on Kupffer cells by interfering with their phagocytic cap­
ability. Blickens and DiLuzio (1965), studying the metabolism of methyl 
palmitate, concluded that its depressive effect on RES activity was not 
due to either physical saturation of phagocytic cells or to the .formation 
of methanol resulting from hydrolysis of the lipid.
The possibility that methyl palmitate might decrease the serum 
opsonic activity of treated mice and, therefore, interfere with phago- 
cystosis of subsequently introduced materials, was investigated by Saba 
and DiLuzio (1968). They found, however, that oponsic activity was only 
slightly reduced and was not a significant factor in methyl palmitate- 
mediated RES depression.
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In summary, the available evidence suggests that methyl palmi­
tate depresses the phagocytic ability of the hepatic and splenic macro­
phages by some mechanism other than physical saturation or necrosis of 
these cells, the production of methanol or the removal of serum opsonins.
Summary
Ethyl stearate, cholesterol oleate, ethyl palmitate and methyl 
palmitate have all been shown to depress the phagocytic capacity of the 
RES. Although direct comparisons have not been reported, methyl palmi­
tate probably exerts the most profound and long lasting depression, 
followed by ethyl stearate, ethyl palmitate and cholesterol oleate. With 
the exception of methyl palmitate, all of these lipids have been shown 
to produce splenic necrosis of varying severity. Necrosis of the liver 
has also been observed following treatment with ethyl stearate and chol­
esterol oleate. Thus, it may be that these materials act through a cyto­
toxic mechanism. The mechanism of action of methyl palmitate is more 
puzzling, as it has not been shown to be toxic to either hepatic or 
splenic tissue.
Lipids offer several advantages over the dyes and other inert 
materials used as RES "blockaders." For example, lipids are specific 
for the RES and do not cause undesirable side effects. Their effect is 
evident within a few hours and is of considerably longer duration. Fin­
ally, no period of hyperactivity follows when their effect has worn off. 
Thus, lipids are well suited for studying RES function.
Evidence for RES Participation in the Immune Response
A vast amount of evidence has accumulated over the past 10-15
11
years implicating the macrophage as an important and essential component 
of many immune systems. A complete review of the literature would be a 
Herculean task and is not within the scope of this work. Rather, the 
various approaches which have been employed in these investigations will 
be discussed and examples of pertinent results will be presented. The 
reader is referred to the excellent reviews of Sulitzeanu (1968) and 
Unanue and Cerottini (1970) for more comprehensive coverage of this com­
plex subject.
Ribonucleic Acid Transfer
One of the first lines of evidence which suggested that the 
macrophage played a role in the immune response was the observation that 
antigen fragments were found associated with ribonucleic acid (RNA) ex­
tracts of these cells. This phenomenon was first observed by Garvey and 
Campbell (1957). While studying the retention of bovine serum albumin 
(BSA) in rabbits following intravenous injection, they found that frag­
ments of BSA complexed to RNA isolated from liver macrophages could be 
detected after several months. Comparison of the immunogenicity of these 
complexes and the original BSA revealed the former to be 100 times more 
effective than the latter in sensitizing guinea pigs as measured by the 
Schultz-Dale reaction.
Fishman (1959, 1961) and Fishman and Adler (1963) found that 
cell-free filtrates from rat macrophages, which had been incubated with 
T2 bacteriophage, evoked the synthesis of specific antibody in cultures 
of lymph node cells from normal rats. Further study revealed the induc­
ing factor to be species specific, ribonuclease sensitive and present in 
low molecular weight RNA fractions (Fishman, Hammerstrom and Bond, 1963).
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Friedman, et al. (1965), studying Fishman and Adler's system, confirmed 
and extended their observations. They found that RNA from macrophages 
incubated with T2 phage, when injected into mice previously immunized 
with this phage, elicited a secondary antibody response. This finding, 
plus the additional observation that treatment of macrophage RNA with 
ribonuclease did not completely eliminate its capacity to elicit anti­
body synthesis in the lymph node system, led these investigators to search 
for antigen or antigenic fragments associated with the RNA. Employing 
a micro method for complement fixation, they detected several T2 phage 
antigens in the RNA. Further investigation of this system by Fishman 
and Adler (1967) revealed the presence of two distinct RNA fractions from 
stimulated macrophages. One fraction, apparently free of antigen, medi­
ated the 19S (IgM) antibody response. The other RNA fraction was com­
plexed with antigen and was responsible for 7S (IgG) antibody formation. 
Both components of the RNA-antigen complex were found to be essential to 
its immunogenic function. Although technical limitations prevent proof 
of the absence of antigen in RNA responsible for the IgM response, sever­
al indirect lines of evidence are consistent with this view. For example, 
the IgM produced as a result of stimulation with this RNA fraction always 
carried the allotypic markers of the macrophage donor, suggesting a mes­
senger role for the RNA inducing 19S antibody production by cells which 
received multiple hits with this RNA. If actinomycin D was added to the 
macrophage-antigen incubation mixture the resultant RNA stimulated IgG 
production only. This suggested that the RNA involved in the IgM re­
sponse was newly formed following exposure to antigen, whereas the RNA 
complexed with antigen and responsible for the IgG response was preformed
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within the macrophage. DNA-RNA hybridization studies have also suggested 
the formation of a new species of RNA following the exposure of macro­
phages to antigen (Cohen, 1968).
Askonas and Rhodes (1965) reported that murine peritoneal cells 
degraded the soluble antigen, hemocyanin, into fragments which became 
complexed with RNA. These complexes were 20 times more immunogenic than 
hemocyanin alone. RNA preparations obtained from peritoneal cells im­
mediately after the addition of hemacyanin were also immunogenic. They 
concluded, therefore, that the immunogenicity of the RNA preparations 
could not be attributed to the formation of a specific new messenger RNA 
by macrophages following antigen exposure. They stated that although 
antigen processing enhanced immunogenicity in their system, it was not 
essential for antibody synthesis. Macrophages may simply serve as anti­
gen storage depots. Complexing with RNA might protect the antigen from 
enzymatic degradation by lysosomal enzymes.
Recently, Pinchuck, et (1968), using a well defined system 
consisting of inbred animals and synthetic antigens, were able to demon­
strate the formation of RNA-antigen complexes. When normal macrophages 
were incubated with a synthetic polypeptide, an RNA-antigen complex was 
obtained which evoked an immune response in mice which normally responded 
poorly, if at all, to the antigen. The response was specific for the 
polymer. If this RNA extract was incubated with a different synthetic 
polymer it failed to elicit an antibody response specific for the second 
antigen.
The recent findings of Roelants and Goodman (1968, 1969) re­
quire that experiments of this nature be interpreted with caution. They
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have presented evidence which suggests that RNA-antigen complexes may 
not have a physiologically significant function in the induction of an 
immune response. This suggestion was based on the failure to demonstrate 
any correlation between a molecule's immunogenic capacity and its ability 
to complex with RNA. They further noted that complex formation was non­
specific, i.e., antigen complexed as readily with HeLa cell RNA as with 
macrophage RNA.
Investigations of a different nature, however, have also sug­
gested that RNA plays an active role in eliciting an immune response. 
Mannick and Egdahl (1962) demonstrated accelerated rejection of skin 
grafts in rabbits following injection of autologous spleen cells which 
had been incubated vitro with homologous RNA extracted from lymph 
nodes of an animal sensitive to the graft donor. Exposure of the RNA 
preparation to ribonuclease abolished its sensitizing ability. RNA ex­
tracted from rabbits immunized to an unrelated antigen did not display 
this heightened immunogenicity. Apparently a specific type of RNA is 
involved in the transfer of transplantation immunity.
Cohen and Parks (1964) extracted RNA from the spleens of mice 
immunized with sheep red blood cells (SRBC) and found that it would con­
vert nonimmume isologous spleen cells into antibody-producing cells. 
Conversion occurred in the presence of trypsin, pronase, both alpha and 
beta amylase and deoxyribonuclease but was inhibited by chloramphenicol 
and ribonuclease (Cohen, et ^ . , 1965). Donor RNA and recipient cell 
crosses between 4 mouse strains revealed a degree of strain specificity. 
Low doses of 5-fluoro-2-deoxyuridine had an adjuvant effect on this sys­
tem. Partially degraded RNA from immunized mice exerted a specific
15
inhibitory effect on antibody induction by intact RNA (Cohen, 1967).
The importance of RNA in the induction of cellular resistance 
was demonstrated by Fong, £t (1963). Ribosomal RNA extracted from 
histiocytes of rabbits immunized with Bacillus Calmette-Guerin (BCG) was 
found to initiate development of cellular immunity in normal rabbits.
Whole Cell Transfer Studies
Feldman and Gallily (1967) concluded, from a series of investi­
gations, that both the macrophage and the lymphocyte are essential for 
antibody production following exposure to antigen. Employing C57BL/6 
mice and a Shigella antigen system they demonstrated that normal peri­
toneal macrophages incubated ̂  vitro with antigen would elicit an anti­
body response in sublethally irradiated recipients which could not re­
spond to the antigen alone. Appropriate controls excluded the possibi­
lity that the response was due to lymphoid cells contaminating the macro­
phage preparation or that macrophages themselves might be producing an­
tibody. Cell reconstruction experiments in lethally irradiated recipi­
ents added further support to their two cell requirement hypothesis.
The only cell recipients which produced a significant titer of agglutin­
ating antibodies were those which had been reconstructed with normal 
lymphocytes plus macrophages previously incubated with antigen. A fur­
ther finding was that irradiation of macrophages prior to their reaction 
with antigen abrogated their capacity to elicit an immune response. 
Irradiation did not decrease the capacity of macrophages to phagocytize 
SRBC. Therefore, it appeared that the immunosuppressive effect of ir­
radiation was due to an interference with antigen processing within the 
macrophage.
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Further studies on the macrophage reconstitution of sublethally 
irradiated mice (Gershon and Feldman, 1968) confirmed the above obser­
vations with Shigella paradysenteriae. However, when these experiments 
were repeated using SRBC in place of the Shigella antigen no such recon­
stitution of the immune response could be achieved despite lower doses 
of irradiation and the use of phagocytosis-enhancing incubation media.
The investigators suggested two possible explanations for this apparent 
discrepancy in the function of the immune system. In recent, unpublished 
work they have shown that when normal thymus explants were added to 
spleen organ cultures from irradiated animals, previously inoculated with 
macrophages and Shigella antigen in vitro, an antibody response ensued. 
Thus, it appeared that lymphoid cells had regenerated and regained im­
munocompétence following irradiation due to thymic influence. They sug­
gested that a temporal relationship may exist between the return of im­
mune competence following irradiation and the type of antigen under 
study. On the other hand, a second cell type, more radiosensitive than 
the macrophage, may be required for the anti-SRBC response but not for 
the anti-Shigella response. This cell may be similar to, or identical 
with, the thymus-dependent, antigen reactive cell recently described by 
Mitchell and Miller (1968) and thought to be involved in the production 
of hemolysins to SRBC.
Seemingly contradictory results were reported by Argyris and 
Askonas (1968). Peritoneal cell exudates were obtained from C3H mice 
following intraperitoneal administration of antigen (formalin-killed 
penumococci or capsular polysaccharide). Macrophage-rich fractions of 
these cell exudates failed to elicit a significant antibody response
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when transferred to x-irradiated, syngeneic recipients. However, non­
irradiated recipients responded with high titers when similarily treated. 
The conflicting results of this study and those of Gallily and Feldman 
may be related to the level of irradiation to which the recipients were 
subjected. In this study the recipients received 700-800 R, whereas in 
the Gallily and Feldman study they received 550 R. In the latter study 
the response was significantly decreased in recipient animals irradiated 
with higher doses (750-900 R). Other differences in the two systems were 
the antigen and mouse strain employed as well as the method of antigen- 
macrophage reaction.
Pribnow and Silverman (1967) studied the radiosensitivity of 
rabbit macrophages and their role in eliciting an antibody response to 
bovine gamma globulin (BGG). They found that normal peritoneal macro­
phages, sensitized in vitro with BGG, would initiate antibody synthesis 
in non-irradiated recipients but not in those exposed to 450 R unless 
normal lymphoid cells were given simultaneously. Of even greater in­
terest was the finding that macrophages from irradiated donors were in­
capable of eliciting an immune response in irradiated recipients even in 
the presence of normal lymphoid cells in the latter. From these data 
they concluded that antigen processing by macrophages represents the 
initial radiosensitive phase of antibody formation in their system.
Unanue and Askonas (1968) studied the immunogenicity and radio­
sensitivity of macrophage-associated Maia squinado hemocyanin (MSH).
CBA mice were injected intraperitoneally with a proteose-peptone solu­
tion 3 days prior to antigen administration, to augment the macrophage 
concentration of the cell population. MSH was injected intraperitoneally
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and the peritoneal cell exudates subsequently obtained consisted of 80-90 
percent macrophages, 75 percent of which contained MSH. Neither the sol­
uble antigen nor the macrophage-associated MSH could elicit a primary re­
sponse upon transfer to normal recipients. However, both could prime re­
cipients for a secondary response, although the macrophage-associated 
antigen was much more effective. The macrophage-held MSH was also able 
to elicit a secondary response in x-irradiated (660-750 R) recipients 
provided lymphoid cells from normal donors were also transferred. The 
immunogenicity of the cell-associated MSH persisted for 3 days and was 
associated with approximately 10 percent of the original MSH taken up by 
the macrophages which was not rapidly catabolized, therefore allowing 
sufficient time for reaction with lymphoid cells. A further finding was 
that x-irradiation (750 R) of normal or protease-peptone stimulated macro­
phage donors did not impair the immunogenicity of the macrophage-asso­
ciated hemocyanin. Thus, radiosensitivity of macrophages appears to vary 
with the immune system.
The same experimental design was employed by Mitchison (1969) 
to compare the immunogenicity of several protein antigens (bovine serum 
albumin, human serum albumin, lysozyme and ovalbumin) in free form and 
after uptake by peritoneal exudate cells (PEC). Mitchison's findings 
were similar to those of Askonas and Rhodes. In general, macrophage- 
bound protein antigens induced primary immune responses more readily than 
the free form of the antigen. Irradiation of PEC donors before, but not 
after, administration of the antigen inhibited immunization upon transfer 
to a recipient. PEC from tolerant donors could effectively immunize 
normal recipients. However, tolerant recipients were not immunized by
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PEC from normal donors.
Frisch and Wilson (1969) studied the effect of macrophage recon­
stitution on the immune response to SRBC in C3H mice which had been im- 
munosuppressed by either sublethal irradiation (550 R) or the drugs, 
cycloleucine and Cytotoxan. Peritoneal cell exudates were obtained from 
normal donors 4 days following intraperitoneal injection of thioglycol- 
late medium. The immune response was assayed by the plaque-forming cell 
technique or by hemagglutination. The transfer of normal macrophages 
plus SRBC elicited a primary immune response in irradiated recipients, 
whereas comparable amounts of spleen cell suspensions were ineffective. 
Macrophage-antigen mixtures from normal or from Cytotoxan-treated donors 
also elicited a primary response in cycloleucine suppressed recipients. 
Similar cell preparations from cyloleucine-treated donors as well as 
normal spleen cell suspensions were not effective, however. Cycloleucine- 
treated macrophages were no less viable and no less capable of phagocy- 
tizing SRBC than were normal macrophages. Therefore, these data support 
the hypothesis that antigen processing by macrophages is a prerequisite 
step in the induction of a primary immune response.
Summary
Investigations employing a macrophage transfer system have de­
monstrated that macrophage-associated antigen is capable of eliciting 
an immune response in recipient animals. They do not, however, prove 
that macrophages are essential components of the immune mechanism. Such 
experiments have demonstrated, however, thatmacrophages are not antibody 
synthesizing cells. It is difficult to evaluate contradictory findings, 
such as reported above, because of the variations in experimental design.
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Certainly the ability to respond to immunogenic stimuli differs with the 
animal species and strain employed. Similarly, antigens vary in their 
immunogenicity and a wide variety have been used in the above experiments 
(SRBC, bacteria and proteins). In some cases irritants were employed to 
collect peritoneal cell exudates rich in macrophages. One wonders what 
effect, if any, these irritants have on the already heterogeneous macro­
phage population. The time interval between administration of the irri­
tant and collection of the cell exudates varied from a few hours up to 
several days in the above experiments. This could also be a factor which 
might influence the subsequent response. Differences in the radiosensi­
tivity of macrophages were also reported. These differences might be 
explained by variation in dose of x-irradiation or time lapse between 
irradiation and cell collection. It is also possible that irritants 
alter macrophage susceptibility to radiation damage and, furthermore, 
cells may vary in their response to irradiation vitro as opposed to 
an in vivo environment. Whatever the exact effect of irradiation on 
macrophages, it apparently operates at the processing stage rather than 
at the engulfment stage.
In drawing conclusions from data obtained in this manner, it 
is implicitly assumed that peritoneal macrophages handle antigen in the 
same manner as their splenic and hepatic counterparts. This may or may 
not be so. Peritoneal cells may serve simply to bind antigen and trans­
port it to splenic macrophages. Evidence for such transport has been
198reported by Roser (1965, 1968). Macrophages labeled with Au were 
traced to the spleens and livers of the intraperitoneally injected reci­
pients .
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These investigations have demonstrated that macrophage uptake 
is an effective means of enhancing the immunogenic potency of many, al­
though not all, antigens. In general, antigens which are normally poorly 
phagocytized ^  vivo displayed increased immunogenicity following incuba­
tion with macrophages. Immunogenic enhancement was not observed when 
antigens which are readily phagocytized in vivo were employed.
In Vitro Cell Interaction
The dependence of antibody formation on the interaction of two 
cell types was demonstrated by Hosier (1967) in an vitro system. He 
separated a suspension of mouse spleen cells into macrophage-rich and 
lymphocyte-rich populations on the basis of the ability of the former 
cells to adhere to a plastic surface. The incubation of each of these 
populations with SRBC did not result in hemolysin production which could 
be detected by the Jerne plaque assay. However, if both cell popula­
tions were cultured together in the presence of SRBC a significant im­
mune response was evident.
Roseman (1969), using Hosier’s technique to separate splenic 
lymphocytes and macrophages, confirmed the observation that both cell 
types were required for the in vitro antibody response to SRBC. Further, 
he demonstrated that the lymphoid cells were highly radiosensitive, 
whereas macrophages were not affected by doses as high as 1000 R.
Employing a similar cell separation and recombination technique. 
Pierce (1969) demonstrated the necessity for macrophage-lymphocyte co­
operation to elicit a primary response i^ vitro, but not for a secondary 
response. Subsequently, Pierce and Benacerraf (1969) reported that in­
teraction between antigen-treated macrophages and lymphocytes is
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effectively completed within 24 hours incubation in vitro. Thereafter, 
the "activated" lymphocytes develop into antibody synthesizing cells in 
the absence of native antigen, macrophages and cell clusters.
An vitro culture system was employed by Forbes (1969) to 
compare the effectiveness of macrophages and lymphocytes from normal and 
tolerant mice in eliciting a primary immune response. Macrophages from 
normal and tolerant mice were equally effective in generating plaque- 
forming cells (PFC). However, splenic lymphocytes from tolerant animals 
were unable to develop into PFC when incubated with normal macrophages. 
Thus, it appeared that the tolerance "lesion" was at the level of the 
lymphocyte in this model. In contrast, Wu and Trice (1967) demonstrated 
that unresponsiveness to Klebsiella pneumoniae capsular antigen could 
be terminated by passive transfer of peritoneal cells, but not spleen 
cells, from either normal or unresponsive donor mice. They concluded, 
therefore, that in their system the tolerance "lesion" resides in the 
macrophage.
The blastogénie response to antigenic stimulation of glass 
bead column-purified lymphocytes was markedly reduced when compared to 
that of unseparated leucocyte suspensions (Hersh and Harris, 1968). 
Culturing these purified lymphocyte preparations on macrophage mono­
layers resulted in partial to complete restoration of blastogenesis, 
providing the two cell populations were not separated by a semi-perme­
able membrane. Similar results were obtained when blastogenesis was 
measured by the incorporation of tritiated thymidine into the DNA of 
the purified lymphocytes.
Using similar techniques, Gordon (1968) demonstrated a
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requirement for macrophage interaction in the mixed leucocyte culture 
reaction. Similar observations that macrophages are required for immuno- 
logically induced lymphocyte transformation have been made by Cline and 
Swett (1968) and Oppenheim, e^ (1968).
Effect of RES Stimulation on the Immune Response 
The observation that RES hyperactivity often enhances various 
immunological phenomena lends further support to the concept of the mac­
rophage as an integral component of the immune mechanism. Zymosan, a 
powerful RES stimulant, greatly enhanced hemolysin formation in rats 
when given as early as one month prior to, or as late as two days after 
antigen administration (Cutler, 1960). Glucan, a highly purified poly­
saccharide isolated from zymosan (Riggi and DiLuzio, 1961), also serves 
dually as a stimulant of RES activity and antibody formation against 
SRBC in mice (Wooles and DiLuzio, 1963; Morrow and DiLuzio, 1965).
Halpem, ^  al. (1958), observed that mice infected with BCG 
not only displayed RES hyperactivity but also produced Eberthella typhi 
anti-H and anti-0 agglutinins of much higher titer and over a longer 
period of time than did control mice. Further, Balner, e^ (1962) 
found that female mice injected with BCG (to induce RES hyperfunction) 
demonstrated accelerated rejection of male skin isografts and concluded 
that this was due to an enhanced immune response.
An association between the RES and the immune mechanism was 
demonstrated by the failure of homologous and heterologous bone marrow 
transplants to survive in lethally irradiated mice which had been treated 
with glucan to induce a hyperfunctional state of the RES prior to irra­
diation (Wooles and DiLuzio, 1962). The increased mortality of
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homologous and heterologous radiation chimeras treated with glucan 
(Wooles and DiLuzio, 1964) provides further evidence that the RES plays 
a significant role in the immune response.
Oncolytic activity toward various foreign and experimental tu­
mors has also been observed with glucan (Diller, ejt , 1964) and 
zymosan and BCG (Old, et al., 1960).
Evidence for Lack of RES Participation in Tolerance Induction
Studies with Neonatal Animals 
The first observation of tolerance induction to a protein anti­
gen via neonatal injection occurred quite by accident. Hanan and Oyama 
(1954), intending to study the effect of BSA on gamma globulin levels 
in young rabbits, repeatedly injected these animals with the protein 
and discovered that they did not form anti-BSA precipitins, sensitize 
guinea pigs for passive anaphylaxis or give an Arthus reaction. Through­
out the ensuing years it has been demonstrated repeatedly that, within 
a species and for a given antigen, tolerance can be induced in neonates 
with considerably greater ease than in adult animals. This could be 
explained by postulating that the RES of newborn animals has not com­
pletely matured by the time of birth if this system is, indeed, an 
essential and integral part of the immune mechanism. Histiologic and 
functional studies of the phagocytic phenomenon in foetal and neonatal 
animals support this view. A functional, although immature, RES has 
been demonstrated in foetal chicks (Karthigasu, at , 1965) and foetal 
rats (Reade and Jenkin, 1965). Sixteen day old foetal rats were shown 
to ingest both bacteria and carbon particles. The efficiency of
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phagocytosis gradually increased up to parturition. It continued to in­
crease after birth up to 3 weeks, then declined in the adult and aged 
animal (Benacerraf, £t al., 1957). The phagocytic cells of foetal 
chicks and rats were extremely limited in their bactericidal capacity 
(Karthigasu, e^ ̂ . , 1965; Reade and Jenkin, 1965). Ten day old neonatal 
rats had developed some bacteriostatic capability but bactericidal acti­
vity was not evident before 21 days of age.
Mitchell and Nossal (1966) observed a marked difference in the 
handling of Salmonella flagellar antigens in newborn and adult rats. In 
adults the antigens were phagocytized efficiently and were concentrated 
in the lymphoid follicles. Phagocytosis was never as pronounced in ne­
onates and the antigen was distributed diffusely throughout the lymphoid 
tissue, including the thymus.
Martin (1966) employed a different approach to evaluate the 
functional maturity of the phagocytic system of neonates. He found that 
newborn rabbits, injected with tolerogenic doses of BSA plus peritoneal 
macrophages from normal, adult rabbits, responded with immunity. Similar 
findings in newborn mice were reported by Argyris (1968). Day old mice, 
given adult peritoneal macrophages and sensitized with SRBC 3 days later, 
developed an enhanced plaque-forming cell response as compared to con­
trol mice. The enhancement of immunity in neonates conferred by adult 
macrophages was not due to a non-specific adjuvant action, as non-viable 
macrophages were without effect. Further, in Martin's experiment, BSA 
in Freund's adjuvant did not sensitize rabbits under 5 days of age. 
Findings such as these strongly support the contention that the ease of 
tolerance induction in newborn animals is directly related to the lack
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of a functional antigen-processing system in the form of mature macro­
phages .
Physical State of the Antigen
The physical state of antigens influences both the ability to 
induce tolerance and susceptibility to phagocytosis. In general, sol­
uble antigens tend to be tolerogenic, whereas particulate antigens are 
usually good immunogens. Similarly, soluble materials are poorly phago­
cytized, whereas particulate and aggregated substances are phagocytized 
with ease. Serum proteins have been separated into aggregated and 
aggregate-free or soluble fractions by a variety of methods including 
ultracentrifugation, "biological" or animal filtration, fractionation 
on sephadex and DEAE columns and by NagSO^ precipitation. Dresser 
(1961, 1962, 1963) initially demonstrated that soluble BGG, separated 
from the native material by ultracentrifugation, was tolerogenic in 
mice. Dresser's investigations were confirmed and extended by Claman 
(1963) and Dietrich and Weigle (1964). Soluble human gamma globulin 
(HGG), also prepared by ultracentrifugation, has been shown to induce 
tolerance in mice (Gamble, 1966; Weigle and Golub, 1967; Golub and 
Weigle, 1967a) and in rabbits (Biro and Garcia, 1965).
Soluble BSA, prepared by "biological filtration" in a rabbit, 
was tolerogenic in other rabbits (Frei, e^ ̂ . , 1965). However, "biolo­
gical filtration" was not as effective in removing the immunogenic mat­
erial as was either ultracentrifugation or sephadex fractionation (Frei, 
et ad., 1968). In some strains of mice, however, biological filtration 
was more efficient than ultracentrifugation. Golub and Weigle (1969), 
studied the effect of antigen form and mouse strain on the induction of
27
unresponsiveness to HGG. BALB/c mice could not be made tolerant to sol­
uble HGG prepared by ultracentrifugation at 105,000 x g for 1 hour. 
However, if soluble HGG was prepared by biological filtration or by re­
peated NagSO^ precipitation, it was quite tolerogenic for this mouse 
strain.
No attempt has been made to review all the literature on this 
subject. Suffice it to say that of those serum proteins studied, most 
can be made tolerogenic for most species. That the conditions prerequi­
site for tolerance induction vary with different antigens, species and 
even strains within species has been clearly demonstrated by Golub and 
Weigle (1969).
Effect of Altered RES Activity on Tolerance Induction
It is generally believed that immune tolerance and antibody 
formation represent antipodal activities of the immune mechanism. A 
hypothesis, first proposed by Medawar (1963), which has found increasing 
favor among students of the immune response states that the usual result 
of direct contact between competent lymphoid cells and antigen may be 
tolerance, whereas, an antigen that has been phagocytized and appropri­
ately "processed" by macrophages will evoke an immune response. If this 
hypothesis is correct and if the macrophage is the initiating cell in 
the immune response, it should be possible to control, at least parti­
ally, what type of response will follow antigenic stimulation by manipu­
lating the activity of the macrophage population. In other words, a 
tolerogenic material may become immunogenic in an animal whose RES has 
been made sufficiently hyperactive. Conversely, RES depression should 
render an animal tolerant or hyporesponsive to a normally immunogenic
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substance.
RES stimulation. BSA is a relatively poor antigen in rabbits 
and soluble BSA has been shown to produce an unresponsive state in most 
rabbits. Pinckard, e^ (1967, 1968) were able to block the induction 
of unresponsiveness to soluble BSA in rabbits by injecting a heat-killed 
suspension of Corynebacterium parvum intravenously either 6 days prior 
to or simultaneously with the soluble BSA. The mechanism of the adjuvant 
action of this microorganism is not known. Other strains of Ĉ. parvum 
have been observed to cause extensive proliferation of the RES but the 
strain used in these studies did not. It was noted, however, that the 
spleen, liver and lungs of the treated animals developed numerous granu­
lomas containing many macrophages but the significance of this is un­
known. Two additional interesting observations resulted from these 
studies. First, Ĉ. parvum does not act as an adjuvant for antigens which 
are, in themselves, good immunogens. Second, it was not possible to 
block the induction of unresponsiveness in neonatal rabbits. It is 
possible that neonates do not have enough mature or functional macro­
phages to be susceptible to adjuvant action.
A similar adjuvant effect was noted by Mergenhagan, et al.
(1967) using lactic dehydrogenase virus (LDV). If LDV was given to 
BALB/c mice 1 day before or simultaneously with a tolerogenic dose of 
soluble HGG, the mice responded by producing antibody rather than be­
coming tolerant. Similar results were obtained with LDV-infected mice 
injected with soluble rabbit gamma globulin (Howard, et , 1969). The 
mechanism by which LDV converts a tolerogenic stimulus into an immunizing 
one is unknown. However, it was noted that LDV grows and multiplies in
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peritoneal macrophages and, thus, it might alter the function of these 
cells in such a way as to enhance the uptake and/or processing of sol­
uble antigens.
The adjuvant action of bacterial endotoxin on antibody produc­
tion has long been recognized. Claman (1963) was able to block the in­
duction of tolerance to BGG in adult mice by an intravenous injection of 
endotoxin 2 hours following antigen treatment.
Golub and Weigle (1967a) investigated the inhibitory effect of 
endotoxin on the induction of tolerance to soluble HGG in mice. Because 
endotoxin had previously been shown to stimulate phagocytic activity of 
the RES, it was presumed that its inhibitory effect on tolerance induc­
tion was due to its enhancement of RES function. However, this was 
found not to be the case. Endotoxin was observed to be an effective in­
hibitor of tolerance induction regardless of the phagocytic rate of the 
RES. The effect of endotoxin did, however, depend on the time it was 
given in relation to antigen administration. Inhibition was observed 
only when endotoxin was given simultaneously or within 2 days following 
antigen administration. Moreover, a single dose of endotoxin given 
within 3 days before antigen abrogated the inhibitory effect of endotoxin 
given within the 2 day interval following antigen exposure. Other work 
by these investigators has shown that an induction period of 4 days is 
required for the establishment of tolerance to HGG (Golub and Weigle, 
1967b). Thus, this induction period can be divided into endotoxin sensi­
tive and resistant stages. The investigators speculated that immuno­
competent cells are forced to "mature" due to some effect of endotoxin 
during a critical time interval when antigen is present (Golub and Weigle,
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1967a). This does not, however, explain why a prior injection of endo­
toxin abolishes the effect of an inhibitory dose. These findings are 
difficult to reconcile with the "macrophage bypass" theory of tolerance 
induction. Perhaps antigen phagocytosis and processing are requirements 
for both tolerance induction and the immune response. In any case, the 
myriad physiological effects of endotoxin preclude anything more than 
mere speculation at the present time.
Just as Pinckard, e;t al. (1968) were unable to block tolerance 
induction to BSA in neonatal rabbits using Ĉ. parvum as an adjuvant,
Smith (1961) was unable to block tolerance to the same antigen in neon­
ates employing endotoxin as an adjuvant.
RES depression. Cruchaud (1968) studied the effect of RES 
blockade with various particulate and high molecular weight soluble 
materials on the immune response of rabbits to BSA. None of the block­
ading agents employed produced a complete and long lasting RES blockade. 
However, high doses of colloidal carbon or iron, given once or twice 
daily for 5 days prior to antigen administration, resulted in a marked 
inhibition of the primary response in most rabbits and a decreased sec­
ondary response in several animals. Specific immune tolerance was ob­
served in a few animals. The significance of this is, however, diffi­
cult to evaluate as BSA is not a strong immunogen and approximately 15 
percent of the control animals also failed to respond.
The effect of carbon blockade of the RES on both the humoral 
and cellular responses to SRBC was studied by Sabet, at (1968, 1969). 
An intraperitoneal injection of 10 mg of carbon given 24-48 hours prior 
to immunization resulted in an 85-95 percent reduction in the number of
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plaque-forming cells as compared to the controls. There was also a sig­
nificant decrease in serum hemagglutinin and hemolysin titers. Further 
investigation revealed that the carbon-treated mice failed to show a 
secondary response upon rechallenge with the antigen (Sabet and Friedman,
1969). In fact, the response of these mice closely resembled the pri­
mary response of the control animals. Sabet and Friedman hypothesized 
that a specific immunologic "amnesia" rather than tolerance, resulted 
from the RES blockade.
Thorotrast, an RES blockading agent, given to mice 15 hours 
prior to the antigen, suppressed the immune response to aggregated BSA, 
a material highly immunogenic in non-blockaded mice (Kong and Cheng,
1970).
The tridymite form of silica has been shown to be a specific 
macrophage toxin (Kessel, e^ ̂ . , 1963). Allison, e^ (1966) have 
concluded that silica is toxic because, once these particles are in­
gested, they react with lysosomal membranes effecting an increased perme­
ability which allows lytic enzymes to escape into the cytoplasm and 
eventually kill the cell. Upon cell death the ingested silica particles 
are released and can again be phagocytized by other macrophages. Pearsall 
and Weiser (1968) found that tridymite given to allograft recipients 
significantly prolonged the graft survival time. Further, they observed 
that immune macrophages, treated with silica and then incubated with 
tumor cells, had lost their capacity to suppress tumor growth. Thus, it 
would appear that the macrophage has a definite role in transplantation 
and tumor immunity.
The RES depression afforded by various lipids has been discussed
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above. A concomitant immunosuppression has been observed in several in­
stances. DiLuzio and Wooles (1964) observed that pretreatment of mice 
with methyl palmitate drastically suppressed both their primary and sec­
ondary responses to heterologous erythrocytes. Similar findings in 
methyl palmitate-treated rats were reported by Ohbuchi (1968).
Melnick and Friedman (1969) demonstrated the immunosuppressive 
effect of ethyl stearate. Mice treated with this lipid 1 day prior to 
immunization with sheep erythrocytes had a markedly reduced number of 
antibody plaque-forming cells.
Cortisone, also an inhibitor of RES phagocytic activity (Heller, 
1955; Conning and Heppleston, 1966; Nicol and Bilbey, 1958; Weiner, e^ 
al., 1967), has been shown to suppress antibody formation in rats 
(Berglund, 1956) and rabbits (Mountain, 1955).
Although crude preparations of anti-macrophage sera (AMS) were 
prepared as early as 1899 by Metchinikoff, it has only been within the 
last 4 years that purified preparations have been characterized with re­
gard to their effect on RES activity and the immune response. It is 
generally agreed that AMS is cytotoxic to macrophages and greatly reduces 
their phagocytic capacity (Unanue, 1968; Argyris and Plotkin, 1969; 
Despont and Cruchaud, 1969; Hirsch, £t , 1969; Loewi, e^ ̂ . , 1969;
Panijel and Cayeux, 1968). Unanue (1968) studied in some detail the 
effect of AMS on macrophages. Within minutes after an intraperitoneal 
injection of AMS, macrophages were observed to be agglutinated into 
large masses. A few hours later marked cytological changes were evident 
in the cytoplasm and nuclei of the remaining macrophages. When AMS was 
given intravenously, marked alterations were noted in the red pulp of
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the spleen. The sinuses contained a paucity of cells and were hemorrhagic 
and dilated. The white pulp was unaltered, as were the liver, lungs, and 
kidneys. The immunosuppressive effect of AMS is not established. It 
has been reported that treatment of mice with AMS does not alter their 
capacity to respond to immunization with SRBC (Loewi, e^ ̂ . , 1969) or 
to keyhole limpet hemocyanin (Unanue, 1968). On the other hand, Argyris 
and Plotkin (1969) found that AMS did suppress antibody formation to 
SRBC in mice but only if the AMS was given 3 days prior to antigen admin­
istration and, further, only when low doses of antigen were employed.
AMS was ineffective when administered simultaneously with the antigen.
A temporal relationship between AMS treatment and immunization, as well 
as a requirement for low doses of antigen, was also observed by Panijel 
and Cayeux (1968). They found that AMS would suppress the immune res­
ponse to bacteriophage in mice, provided the animals were treated daily 
with AMS from the third day before to the third day after injection of 
a priming dose of antigen. AMS suppression of immunological memory might 
be explained, suggested these investigators, by failure of macrophage- 
associated antigen to persist in an immunogenic form. A similar explana­
tion was proposed by Jennings and Oates (1967) for the immunosuppressive 
effect of certain normal sera and phytohemagglutinin. These substances 
accelerated both the phagocytic activity of peritoneal macrophages and 
the formation of hydrolytic enzymes within these cells. This, then, 
could prevent antibody formation by enhancing the degradation and clear­
ance of the injected antigen. This might also explain the results rer- 
ported by Despont and Cruchaud (1969). They found normal rabbit serum 
to be nearly as immunosuppressive as AMS in mice injected with SRBC or
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diphtheria toxoid.
Immunosuppression by antigen-specific antibody has been achieved 
under certain conditions. Ryder and Schwartz (1969) undertook studies 
to elucidate the site of action of specific antibody. Mice were passively 
immunized at birth and challenged 6 weeks later with SRBC. Their immune 
response was greatly impaired. Binding of the passively administered 
antibody to the SRBC was ruled out as a possible mechanism of immuno­
suppression as was any reaction between lymphoid cells and antibody. It 
appeared that antibody acted at the macrophage level since peritoneal 
macrophages from passively immunized mice, which had subsequently been 
injected with SRBC, failed to elicit an immune response in normal recipi­
ents.
Statement of the Problem 
The problem was an investigation of the role of the RES in 
tolerance induction. The approach, in brief, was to depress the phago­
cytic activity of the RES and determine if this would enhance the ease 
of tolerance induction. Ethyl stearate and methyl palmitate were em­
ployed as RES depressants. Phagocytic activity of the RES was deter­
mined by measuring the intravascular clearance rate of colloidal carbon. 
BALB/cJ mice, a strain noted for its resistance to tolerance induction, 
were employed as test animals and a soluble preparation of HGG was used 
as the antigen. The presence or absence of tolerance was determined by 
the passive hemagglutination technique.
CHAPTER II 
MATERIALS AND METHODS 
Animals
Male BALB/c and C57BL/6 mice, obtained from Jackson Laboratories, 
Bar Harbor, Maine, were employed throughout this study. They were ap­
proximately 5 weeks of age upon receipt and were used experimentally at 
6 weeks of age. Their average weight was 22 gm, with a range of 15-26 
gm. Prior to and during the experimental period all mice were maintained 
on Teklad Mouse/Rat Diet and tap water ̂  libitum.
RES Blockade and -Measurement 
Lipid Emulsions
One gm of ethyl stearate (Eastman Organic Chemicals and K and 
K Laboratories, Inc.) was added to 5.0 ml of 5.0 percent dextrose water 
(Cutter Laboratories) containing 0.04 ml tween-20 (donated by Atlas 
Chemical Industries, Inc.) and heated to 50C. The suspension was then 
sonified (Branson Bonifier, Model S75) for 10 seconds. The resulting 
emulsion was maintained at 50C to prevent solidification of the lipid.
The methyl palmitate (Nutritional Biochemical Corporation and
Applied Science Laboratories) emulsion was prepared in a similar manner.
One gm of the lipid was added to 20 ml dextrose water containing 0.02 ml
tween-20, heated and sonified as described above. This emulsion was
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also maintained at 50C to prevent solidification.
Both lipid emulsions were prepared immediately prior to use.
The mice were anesthetized with ether and injected via a tail vein. To 
effect vasodilation and facilitate intravenous injections, the tails were 
immersed in warm water for a brief period. Control animals were given 
an equal volume of 5 percent dextrose water containing the appropriate 
amount of tween-20.
Histological Studies 
Spleens and livers were removed from mice 1 or 4 days after an 
intravenous injection of either ethyl stearate, methyl palmitate, or a 
mixture of these two lipids. Similar organs were obtained from normal 
mice as well as from animals injected with tween-20 in dextrose water.
All tissues were placed in 10 percent formalin and sent to the histo­
chemistry laboratory for section preparation. Conventional histological 
staining of the tissues with hematoxylin and eosin (H and E) and with a 
lipid-specific stain was performed on paraffin fixed tissues. Dr. 
Florence Bannerjee. Department of Pathology, examined and evaluated the 
sections.
Carbon Clearance 
The phagocytic function of the RES was measured by determining 
the intravascular clearance rate of colloidal carbon (Cll-1431a, Guenther 
Wagner, Pelikan-Werke, Hanover, Germany) as described by Halpern, et al. 
(1951). The original carbon suspension was centrifuged at 5,000 rpm for 
15 minutes to remove the larger carbon particles. The carbon concentra­
tion of the supernatant was approximately 90 mg/ml. This suspension was
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diluted in a gelatin (Difco or Knox) solution (prepared with distilled 
water and adjusted to a pH of 7.2 with ammonia) to final concentrations 
of 8 mg carbon/ml and 1.0 percent gelatin.
All mice were anesthetized with an intraperitoneal injection of 
sodium pentabarbital (J. T. Baker Chemical Co. and Abbott Laboratories) 
prior to carbon clearance tests. The anesthetic was prepared by dissolv­
ing 10 mg of sodium pentabarbitol in 1 ml of pyrogen-free, 0.8 percent 
NaCl (saline) (Cutter Laboratories). This solution had to be stored at 
room temperature to prevent flocculation of the solute. The material 
was employed at a dose of 0.1 mg/gm body weight.
A carbon dose of 4 mg/100 gm body weight was administered intra­
venously to each animal. Blood samples were obtained just prior to and 
at 3, 6, 9 and 12 minutes after carbon injection. The samples were 
collected from the retro-orbital venous plexus with a 25 yl capillary 
pipette which had previously been rinsed with a heparin (Fisher Scienti­
fic Co.) solution containing 200 units/ml. Each blood sample was added 
to 2.0 ml of 0.1 percent NagCOg to lyse the erythrocytes. The quantity
of carbon in each sample was determined spectrophotometrically (Bausch
and Lomb Spectronic 20) at a wavelength of 650 my. The pre-injection 
blood sample was used as a blank.
The log concentration of carbon in each blood sample was deter­
mined from a standard curve in which known quantities of carbon in blood 
were plotted against optical density. • When these concentrations were 
plotted against time, a straight line was obtained, the slope of which 
is a constant, K, termed the phagocytic index. The value of K was cal­
culated from the formula derived by Biozzi, et al. (1953), as described
38
in CHAPTER I. The phagocytic index was converted to intravascular half- 
time^ (T/2) by the following formula: T/2 = - — —  -K
Antigens
Human gamma globulin (7S) was purchased from Immunology, Inc.
The same batch (Lot #8691) was used throughout the investigation, both 
for tolerance induction and as the assay antigen for passive hemagglutin­
ation titrations. Human gamma globulin. Fraction II (Lot #J1524), was 
obtained from Mann Research Laboratories, Inc. This material, after 
aggregation, was employed as the immunizing antigen. Pentex, Inc. was 
the supplier of mouse gamma globulin. Fraction II (Lot #9). All anti­
gens were judged pure by immunoelectrophoretic analysis employing the 
method of Hyde, Bennett and Garb (1967) and an LKB 6800 A apparatus.
Two commercial antisera (Hyland) were employed in this analysis; rabbit 
anti-human gamma globulin and goat anti-human serum. In addition, the 
sera of normal mice immunized with aggregated human gamma globulin 5 
weeks earlier were pooled and assayed against whole human serum and 
against human gamma globulin.
Soluble Human Gamma Globulin
A soluble preparation of 78 human gamma globulin (HGG) was used 
as the tolerance inducing material. Lyophilized HGG was dissolved in 
saline and allowed to stand overnight at 4C. Following centrifugation 
at 2,000 rpm for 5 minutes to remove the undissolved material, the super­
natant was centrifuged for 2.5 or 4 hours at 40,000 x g or 100,000 x g
^Half-time (T/2) is the time required for the injected carbon 
to be reduced to one-half its initial concentration in the blood.
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in a Beckman Model L2-65B preparative ultracentrifuge with a Type SW 41 
swinging bucket rotor. The top one-third of the material from each tube, 
containing primarily the monomeric form of the antigen, was carefully 
transferred to a vial with a propipette. This monomeric material was 
designated sHGG. The protein concentration of each sHGG preparation was 
determined spectrophotometrically (Beckman DU Spectrophotometer, Model 
2400) by the method of Kalckar (1947). The appropriate dilutions for 
injection were made in saline. Animals were injected with the sHGG as 
soon as possible after centrifugation, generally within 1 hour.
Heat-Aggregated Human Gamma Globulin 
Cohn Fraction II of HGG was dissolved in saline at a concentra­
tion of 25 mg/ml. After low speed centrifugation to remove the undis­
solved material, the supernatant was dialyzed for 12 hours against 0.08 
M phosphate buffered saline (PBS) (pH 8.0) made up in distilled water.
The dialysate was discarded and a second 12 hour dialysis was performed 
against 0.08 M PBS (pH 8.0) made up in deionized water. The PBS con­
tained 1.8 gm KHgPO^ + 7.6 gm NagHPO^ + 9.0 gm NaCl + 1,000 ml water.
The HGG solution was then centrifuged to remove the precipitate. The 
supernatant was heated at 63C for 20 minutes with occasional stirring, 
then cooled in an ice bath. The aggregated material was collected by 
centrifugation at 2,000 rpm, washed three times in 0.08 M PBS (pH 8.0), 
and resuspended in 20 ml saline. A 1.0 ml aliquot of this suspension 
was digested in 4.0 ml of 0.1 N NaOH. This suspension cleared in 30 
minutes. The protein concentration was determined spectrophotometrically. 
The aggregated HGG (aggHGG) was diluted in saline to a concentration of 
2.0 mg/ml and stored in 4.0 ml aliquots at 4C.
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The aggHGG was employed as the immunizing antigen in all experi­
ments. Each animal received a dose of 0.1 mg aggHGG emulsified in an 
equal volume of incomplete Freund's adjuvant (Difco) and administered 
subcutaneously in a single site.
Tolerance Induction
Experiment Design
The procedure for inducing tolerance is outlined in Table 1. 
BALB/c mice were employed in most experiments because they are known to 
be particularly resistant to the induction of tolerance to protein anti­
gens. C57BL/6 mice were used in one experiment for comparative purposes 
as they are much more susceptible to tolerance induction.
On the first day of an experiment the test and immunization 
control mice were given intravenous injections of the ethyl stearate- 
methyl palmitate emulsion to depress RES activity. Tolerance controls 
received an equivalent amount of tween-20 in 5 percent dextrose water by 
the same route. One day later the test and tolerance control animals 
were injected intraperitoneally with the tolerogenic antigen, sHGG. An 
equal volume of saline was given to the immunization controls. One week 
after tolerization all animals were challenged with 0.1 mg aggHGG in in­
complete Freund's adjuvant, administered subcutaneously. Mice were first 
bled 2 weeks after challenge and then at weekly intervals for 3 more 
weeks. Prior to bleeding, the mice were warmed under a heat lamp for a 
few minutes. Bleedings were accomplished through a transverse incision 




EXPERIMENTAL DESIGN FOR TOLERANCE INDUCTION
BALB/c Mice 




















Ethyl stearate, methyl palmitate 
^Soluble human gamma globulin 
^Aggregated human gamma globulin
^Some animals were treated with dextrose water or with saline. 
Immune response was the same, hence the animals are combined into a 
single tolerance control group.
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Immune Response Assay 
The immune response was measured by passive hemagglutination, 
employing sheep red blood cells (SRBC) obtained from the Colorado Serum 
Co. The cells were preserved in Alsever's solution and were washed 3 
times in 0.08 M PBS (pH 7.4) before use.
HGG was coupled to SRBC with bis diazotized benzidine (BOB).
The BDB was prepared by dissolving 0.161 gm benzidine dihydrochloride 
(Lot #127B-2300, Sigma Chemical Co.) in 22.5 ml of 0.25 N HCl at -2C.
To this was added 2.5 ml of an aqueous solution of 3.5 percent NaNOg, 
previously cooled to -2C. The NaNOg solution was added slowly with 
stirring over a period of 1 minute. The mixture was allowed to react 
for 30 minutes at -2C with intermittent stirring. It was then sealed in 
1 ml aliquots and stored at -IOC.
A modification of the Stavitsky and Arquilla (1955) method was 
employed to couple the HGG to the SRBC. To 2.0 ml of a 4 mg/ml saline 
solution of HGG, previously absorbed with SRBC, the following were added: 
1.6 ml of 0.85 percent saline, 0.1 ml of a 50 percent SRBC (suspended in
0.08 PBS, pH 7.4), 0.5 ml of 1:15 dilution of BDB (diluted in PBS).
This suspension was incubated at room temperature for 15 minutes with 
intermittent, gentle mixing and then centrifuged at 1,500 rpm for 3 
minutes. The supernatant was discarded and the HGG-sensitized SRBC were 
resuspended and washed twice in 2.0 ml of PBS containing 0.2 percent 
gelatin (PBSG). Following washing the sensitized cells were resuspended 
in 2.5 ml of PBSG. This suspension was finally diluted 1:4 in PBS for 
use in the hemagglutination assay. Control or unsensitized SRBC were 
prepared in exactly the same manner except that 2.0 ml of PBSG were
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substituted for the HGG.
Disposable, microtiter "V" plates (Cooke Engineering Co. and 
Linbro Chemical Co.) were utilized for the passive hemagglutination 
assays. Each serum was titrated in two diluents, PBSG and a 5 percent 
aqueous solution of bovine serum albumin (BSA) (Mann Research Labora­
tories, Inc.).
The stepwise procedure was as follows:
1. 25 yl of diluent was added to each well.
2. 25 y1 of mouse serum was added to the first well in each row.
3. Serial, twofold dilutions of the serum were made up to, but not 
including, the last well in the row.
4. 25 yl of HGG-sensitized SRBC were added to each well including 
the last one in the row. The last well, therefore, served as 
a control for non-specific hemagglutination of the sensitized 
cells.
5. A 1:100 dilution of rabbit anti-HGG serum (Hyland) was also 
titrated as a positive control.
6. This procedure was repeated using unsensitized SRBC as a control 
for non-specific reactions between the serum and SRBC.
7. The plates were incubated at room temperature and read at 4 and 
12 hours.
All titers were expressed as logg units of the reciprocal of 
the highest dilution giving any indication of hemagglutination. A thin, 
uniform lawn of SRBC covering the entire bottom surface of the well was 
designated as complete hemagglutination. An irregular lawn of cells was 
interpreted as incomplete hemagglutination. Negative hemagglutination 
was evidenced by a round, compact button of SRBC in the center of the 
well surface. Figure 2 shows a sample titration of eight sera. Each 
serum was serially diluted in the horizontal rows, i.e., wells one 
through eleven. The logg titers were read as follows: serum #1=3;
.5 'I I a :) 10
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Figure 2— Passive hemagglutination assays of eight mouse sera.
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serum #2=1; serum #3=4; serum #4=6; serum #5=5; serum #6=6; serum #7=4; 
serum #8=5. Passive hemagglutination assays were done in duplicate 
whenever the volume of serum permitted and titers reported are the aver­
age of these duplicate titrations.
CHAPTER III
RESULTS
Effect of Anesthesia on RES Function 
Carbon clearance tests can be carried out with greater ease, 
rapidity and accuracy in anesthetized animals. Sodium pentabarbital is 
the anesthetic agent of choice for mice when a relatively long duration 
of anesthesia is required (Taber and Irwin, 1969). However, virtually 
no studies have been done to evaluate the effect of anesthesia on physio­
logical function in mice. Therefore, it was necessary to determine what 
effect, if any, sodium pentabarbital had on normal carbon clearance 
rates. Two test groups, done on different days, received 0.1 ml (2.0 mg) 
of sodium pentabarbital intraperitoneally. The control group was in­
jected with an equal volume of sterile, physiological saline by the 
same route. The results are given in Table 2 and clearly demonstrate 
no significant difference in the clearance rates of the 3 groups of 
animals.
Effect of Lipids on RES Function 
Ethyl Stearate
The effect of ethyl stearate on phagocytic activity was com­
pared using ethyl stearate from two suppliers. Carbon clearance rates 




EFFECT OF ANESTHESIA ON THE CARBON CLEARANCE 








Yes 4 15.4 ± 3.1 9.8 - 23.7
Yes 5 11.6 ± 2.5 6.5 - 19.7
No^ 7 14.7 ± 1.0 11.4 - 18.3
^alf-time. Values are means ± standard error. 
^Unanesthetized animals received an equal volume of saline.
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TABLE 3
EFFECT OF ETHYL STEARATE OBTAINED FROM K AND K
LABORATORIES, INC. ON RES FUNCTION
Number Carbon
Ethyl Stearate of T/2&
Dose (mg) Animals (min.) Range
40 7 72.5 ± 14.7 36.3 - 150.5
60 7 109.1 ± 27.7 44.9 - 231.5
80 6 74.7 ± 7.1 56.8 - 100.3
120 5 145.4 ± 40.8 64.0 - 301.0
Controls 8 15.8 ± 1.8 10.9 - 27.4
^alf--time. Values are means ± standard error.
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and 4 show the effect of ethyl stearate obtained from K and K Labora­
tories, Inc. and Eastman Organic Chemicals, respectively. The data con­
tained in Table 4 were compiled from experiments done on different days. 
Therefore, the effect of slight differences in the daily preparation of 
the individual lipid emulsions and carbon suspensions is obviated.
The ethyl stearate preparation obtained from K and K Labora­
tories, Inc., appeared to be slightly more depressive to the RES, but it 
is doubtful that there is any real difference in the effectiveness of 
the two preparations. Also, it appeared that doses from 20 to 80 mg 
were of approximately equal effectiveness. Doses of 80 mg and greater 
had a decidedly toxic effect on the mice (Table 5). Considering the 
relative toxic and RES blockading effects, it was decided that a dose 
of 60 mg would be used in subsequent experiments. Also, the ethyl stear­
ate preparation from Eastman Organic Chemicals was employed in all sub­
sequent work.
Studies were carried out to determine the duration of the de­
pressive effect of ethyl stearate on RES phagocytic activity. Mice were 
injected with 60 mg of ethyl stearate and divided into five groups.
Carbon clearance tests were done at 1, 2, 4, 7, and 10 days following 
administration of the lipid. A few of the lipid-treated animals exhibited 
exceptionally prolonged half-times which suggested some reaction in this 
small group not observed in the majority of the population. These ex­
ceptional animals are discussed for each experiment in which they were 
observed. For statistical purposes, the comparisons of the control 
group means vs test group means did not include these animals. In this 
experiment, and in all subsequent studies on the duration of lipid effect.
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TABLE 4
EFFECT OF ETHYL STEARATE OBTAINED FROM EASTMAN 









20 6 68.6 ± 5.1 44.9 - 81.3
40 5 55.7 ± 5.1 44.9 - 75.2
Control 5 16.0 ± 2.5 9.5 - 21.0
60 8 52.8 ± 7.9 26.6 - 100.3
Control 11 21.3 ± 3.2 12.2 44.9
80 3 89.7 ± 21.8 56.8 - 130.9
120 1 81.3 ± 0 -
Control 3 13.2 ± 1.4 10.6 - 15.3
160 1 231.5 ± 0
Control 5 16.6 ± 2.9 11.1 - 24.5
^alf-time. Values are means ± standard error.
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TABLE 5














dumber of animals surviving/number of animals treated, 
b.K and K Laboratories, Inc. 
^Eastman Organic Chemicals.
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the calculated F values for testing control group means vs. test group 
means at each time interval were determined by the procedure for testing 
simple effects in an unweighted mean analysis for a two-way classifica­
tion as given by Winer (1962). This technique was selected since it
offered a convenient computational procedure for solving the problem of 
unequal cell size and required assumptions no more stringent than those 
of the usual Student's t test where the estimate of error is obtained by 
pooling. The statistic employed, F value, with one degree of freedom 
for the numerator is, of course, equivalent to the "t" test for differ­
ence of two means in that the square root of the F value is the t value.
This analysis allowed the pooling of information in all cells in the 
estimation of experimental error. The robustness of analysis of vari­
ance procedures relative to departures from the normality and homogeneity 
of variance assumptions (Box, 1954) was also an influencing factor in 
the choice of this technique. Although the individual comparison could 
have been made using a non-parametric technique, such as the Mann-Whitney 
U test, there is a loss of power of differentiation with this procedure 
as compared to the selected parametric method.
All animals had significantly depressed phagocytic function 1 
day following treatment with ethyl stearate (Table 6). At 2 days, one 
animal, not shown in the table, was completely suppressed (T/2 - »), six 
were markedly depressed and one displayed a normal clearance rate 
(T/2 - 17.7 minutes). At 4 days, 9 of 11 animals were marginally de­
pressed. By 7 days, half of the animals had regained normal function 
and half were still depressed, 2 quite severely (T/2 - » and 231.5 min­
utes). All animals except one had regained normal or nearly normal
TABLE 6









(min.) Range F Value
1 Test 4 67.5 + 11.0 52.8 100.3 10.19b
1 Control 7 16.1 ± 1.3 12.2 - 22.0
2 Test 7 60.9 ± 14.9 17.7 _ 130.9 8.84^
2 Control 7 12.9 ± 2.0 7.2 - 23.1
4 Test 11 46.3 ± 3.5 30.1 _ 64.0 1.74
4 Control 6 25.0 + 2.4 20.5 - 34.6
7 Test 7 65.4 ± 29.6 13.5 _ 231.5 7.62^
7 Control 6 20.8 ± 3.3 10.6 - 35.0
10 Test 7 27.4 + 6.0 12.1 — 60.2 0.92
10 Control 8 11.9 + 2.0 6.8 - 21.5
^alf-time. Values 
^Significant at 0.05
are means ± standard error, 
level in test of difference between control and test group means.
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function by day 10.
Methyl Palmitate
The effect of methyl palmitate on phagocytic function was com­
pared using methyl palmitate from two sources. The effect of 20 mg and 
40 mg doses of lipid obtained from Nutritional Biochemicals Corp., on 
phagocytic function 24 hours after administration is shown in Table 7.
Two animals, not shown in Table 7, were completely blockaded (T/2 - ») 
by the 20 mg dose, 2 were significantly depressed (T/2 - 143.3 and 88.5 
minutes) and 2 were not depressed (T/2 - 16.4 and 16.1 minutes). The 
40 mg dose depressed 3 of the 4 mice to a marked degree. The toxicity 
of this material is evident from an inspection of the data presented in 
Table 8. Approximately one-third of the treated animals did not survive.
In contrast to the Nutritional Biochemicals Corporation prepara­
tion of methyl palmitate, that supplied by Applied Science Laboratories 
was considerably less toxic (Table 8). The purity of the latter pre­
paration was listed as 99+ percent and this has been confirmed by 
DiLuzio and Wooles (1964). Seventy-three percent of the mice survived 
treatment with a 45 mg dose and 79.0 percent survived a 35 mg dose.
The effect of various doses of this preparation on phagocytic activity 
is shown on Table 9. None of the mice was depressed by the 15 mg dose. 
The 25 mg dose depressed 9 of the 15 animals but 2 of these had T/2 
values approaching the upper limit of carbon half-times of control ani­
mals (t/2 - 56.8 minutes). Approximately one-half of the animals re­
ceiving the 35 mg dose were depressed. The 45 mg dose exhibited the 
greatest depressive effect as well as the most toxicity. All animals 
were severely depressed by this dose of methyl palmitate.
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TABLE 7
EFFECT OF METHYL PALMITATE OBTAINED FROM NUTRITIONAL 
BIOCHEMICALS CORPORATION ON RES FUNCTION 









20 4 66.1 ± 30.9 16.1 - 143.3
Controls 9 19.8 ± 2.0 11.3 - 29.2
40 4 55.4 ± 11.8 28.1 - 75.2
Controls 3 25.9 ± 2.3 22.0 - 30.1
^alf-time. Values are means ± standard error.
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TABLE 8














dumber of animals surviving/number of animals treated, 




EFFECT OF METHYL PALMITATE OBTAINED FROM APPLIED 
SCIENCE LABORATORIES ON RES FUNCTION 









15 4 24.8 ± 4.1 18.2 - 36.3
25 15 73.6 ± 9.9 26.6 - 150.5
35 11 68.2 ± 12.6 13.9 - 177.1
45 4 120.5 ± 12.2 100.3 - 150.5
Controls 15 17.4 ± 3.6 4.6 - 52.8
^Half-time. Values are means ± standard error.
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The duration of the depressive effect of both preparations of 
methyl palmitate was determined. The results of the experiment using 
methyl palmitate obtained from Nutritional Biochemicals Corp. are shown 
in Table 10. Two animals, not shown in the table, were completely de­
pressed, 2 were significantly depressed and 2 were only slightly affected 
1 day following treatment. At 4 days all treated animals had prolonged 
clearance times. At 7 days 1 animal was quite depressed (T/2 - 273.6 
minutes), 1 had regained normal function and the remaining 3 had clear­
ance rates approaching those of the controls. By 10 days all animals 
had normal or nearly normal clearance rates.
The results of a similar experiment, using a 45 mg dose of 
methyl palmitate obtained from Applied Science Laboratories, are shown 
in Table 11. At day 1 all animals were greatly depressed. One animal, 
not shown in the table, was exceedingly depressed (T/2 - 1,003.3 minutes). 
Again, at day 2, all animals exhibited decreased RES activity but the 
depression was not as marked as at day 1. The results shown for day 4 
are equivocal. They represent the averages of experiments done on three 
separate occasions. In 2 of these experiments several of the control 
animals had considerably longer half-times than were usually found. 
Further, in one case, 3 of 4 test animals were not suppressed at all. 
Combining all three groups, as was done in Table 11, shows that 11 of 
the 14 test animals were depressed to varying degrees but so were 9 of 
the 21 controls. At day 7 two-thirds of the test group had normal clear­
ance rates and by day 10 all but 1 test animal had normal or nearly nor­
mal half-times.
It was thought that two successive treatments with methyl
TABLE 10
DURATION OF RES DEPRESSION FOLLOWING A 20 mg DOSE 












(min. ) Range F Value
1 Test 4 66.1 ± 30.9 16.1 - 143.3 2.87
1 Control 9 19.8 ± 2.0 11.3 - 29.2
4 Test 4 68.4 ± 5.9 56.8 - 81.3 3.83
4 Control 5 14.9 + 2.0 10.7 - 21.5
7 Test 5 73.7 ± 50.0 17.5 - 273.6 5.38^
7 Control 5 10.4 ± 1.3 8.1 - 17.7
10 Test 5 24.2 ± 4.1 16.4 - 39.1 0.12
10 Control 5 14.7 ± 3.3 6.3 - 26.6
Ln
VO
Half-time. Values are means ± standard error.
^Significant at 0.05 level in test of difference between control and test group means.
TABLE 11
DURATION OF RES DEPRESSION FOLLOWING A 45 mg 













(min. ) Range F Value
1 Test 4 120.5 ± 12.3 100.3 - 150.5 166.58^
1 Control 10 16.8 ± 4.1 9.1 52.8
2 Test 6 64.2 ± 10.4 37.6 - 100.3 30.76^
2 Control 6 19.6 ± 1.0 17.7 - 24.5
4 Test 14 44.5 ± 5.9 13.5 - 94.1 5.23^
4 Control 21 26.1 ± 3.1 9.9 - 52.8
7 Test 12 30.8 ± 3.5 14.1 - 50.2 4.30^
7 Control 13 14.2 ± 1.6 7.5 - 25.0
10 Test 4 32.2 ± 5.7 22.1 - 48.5 5.82^
10 Control 5 12.8 ± 1.8 7.5 - 18.5
^Half-time.
^Significant
Values are means ± standard error, 
at 0.05 level in test of difference between control and test group means
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palmitate might prolong the duration of its depressive action. To test 
this hypothesis, mice were given a 25 mg dose of the lipid and, 3 days 
later, a second injection of the same amount. Clearances were done 4,
7 and 10 days after the initial injection. The results are given in 
Table 12. At days 4 and 7 approximately half the test animals had nor­
mal clearance rates and by day 10 all had regained normal function.
Thus, this treatment did not extend the duration of RES depression over 
that produced by a single administration of lipid.
Combined Dose of Ethyl Stearate and Methyl Palmitate 
Since ethyl stearate and methyl palmitate are believed to exert 
their depressive effect on the RES by different mechanisms, it was 
thought that a combined dose of the two lipids might result in a more 
severe and/or prolonged depression than that caused by either lipid 
alone. Animals were divided into 4 test and control groups. The test 
mice received an injection consisting of 30.0 mg of ethyl stearate and 
22.5 mg of methyl palmitate. This combination was not toxic. The re­
sults of this experiment (Table 13) show all treated animals to be sig­
nificantly depressed at days 1 and 4. In fact, at day 1, 2 animals, not 
shown in the table, were completely depressed (T/2 - “). By day 7 one- 
third of the test mice had normal clearance rates. Three of the 12 
treated animals were significantly depressed at day 10; the rest had 
normal or nearly normal half-times. Although these results were not 
markedly different from those employing only 1 lipid at a time, it did 
appear that a somewhat higher -percentage of the test group remained de­
pressed for a slightly longer period of time. In view of this, the two 
lipids were used in conjunction as RES depressive agents in the
TABLE 12
EFFECT OF TWO SUCCESSIVE 25 mg DOSES OF METHYL 
PALMITATE OBTAINED FROM APPLIED SCIENCE 
LABORATORIES ON RES FUNCTION










(min. ) Range F Value
4 Test 11 33.4 ± 2.1 23.7 - 44.9 4.96^
4 Control 5 25.4 ± 3.8 18.5 - 39.1
7 Test 7 25.4 ± 2.7 18.0 - 36.3 14.44^
7 Control 6 11.7 ± 1.9 6.4 - 20.1
10 Test 5 10.7 ± 1.7 7.5 - 17.0 0.20
10 Control 5 9.1 ± 1.4 6.4 - 13.7
Half-time. Values are means ± standard error.
Significant at 0.05 level in test of difference between control and test group means.
TABLE 13
EFFECT OF A COMBINED DOSE OF ETHYL STEARATE AND METHYL 











(min. ) Range F Value
1 Test 12 69.5 ± 13.7 36.3 - 177.1 19.59^
1 Control 13 14.1 ± 3.6 5.2 - 15.0
4 Test 14 43.2 ± 4.4 20.5 - 75.2 8.04^
4 Control 14 7.7 ± 1.2 2.4 - 17.4
7 Test 12 52.1 ± 23.0 12.9 - 301.0 10.99^
7 Control 15 10.6 ± 1.1 3.1 - 18.0
10 Test 12 27.8 ± 3.6 12.2 - 50.2 1.66





are means ± standard error, 
level in test of difference between control and test group means.
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subsequent tolerance induction studies.
The effect of ethyl stearate-methyl palmitate treatment on the 
RES activity of C57BL/6 mice was also determined since this strain, as 
well as BALB/c mice, were employed in the subsequent tolerance induction 
experiments. The results, presented in Table 14, indicate that C57BL/6 
mice are more susceptible than the BALB/c strain to lipid-induced RES 
depression. All but 1 animal (T/2 - 39.1 minutes) were severely depressed 
(T/2's ranged from 130.9 to 1,003.3 minutes) and another, not shown in 
the table was completely depressed (T/2 - ~). The C57BL/6 mice were 
also more sensitive to the toxic effects of the lipid, since 5 of 13 did 
not survive treatment.
Histological Studies
Spleens and livers were removed from mice 1 and 4 days after 
the following treatments: (1) ethyl stearate, (2) methyl palmitate,
(3) the two lipids given together, (4) tween-20 in dextrose water and 
(5) none. Paraffin sections were stained with either hematoxylin and 
eosin or with a lipid stain. The spleens and livers of all animals 
treated with tween-20 in dextrose water were normal as were the livers 
of all the lipid treated animals. Examination of the spleens of those 
animals injected with ethyl stearate revealed marked and diffuse necro­
sis throughout the white pulp with neutrophil infiltration after 24 hours. 
However, the germinal centers were not affected. At 4 days focal areas 
of necrosis were still visible in the white pulp but regeneration had 
begun as evidenced by the marked proliferation of histiocytes and fibro­
blasts. The methyl palmitate-treated animals displayed almost identical 
splenic pathology. Regeneration began somewhat earlier in these animals
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TABLE 14
EFFECT OF ETHYL STEARATE-METHYL PALMITATE ON RES FUNCTION 
OF C57BL/6 MICE 24 HOURS AFTER TREATMENT
Number Carbon
of T/2&
Group Animals (min. ) Range
Lipid-Treated 5 305.5 ± 176.3 39.1 - 1,003.3
Control 13 7.1 ± 0.7 3.2 - 11.2
Half-time. Values are means ± standard error.
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as some histiocyte and fibroblast infiltration was noted 1 day after 
administration of the methyl palmitate. Those animals treated with the 
two lipids in combination also had similar splenic changes. Again, at 
1 day following treatment, marked necrosis of the white pulp with neutro­
phil infiltration was evident. By 4 days focal areas of necrosis were 
observed in both the white and red pulp. Regeneration was also evident 
at this time.
The lipid stain revealed some fat present in the splenic histio­
cytes 4 days after treatment with the combination of lipids. In no 
other instance was fat observed in the liver or spleen sections.
Tolerance Induction
Effect of Centrifugation Speed and Duration on the 
Tolerogenicity of HGG
The tolerogenic or soluble antigen was prepared by ultracentri­
fugation of a saline solution of HGG. It was of interest to know what 
effect, if any, the speed and duration of centrifugation had on the 
tolerogenic property of this antigen. To determine the effect of speed, 
antigen preparations were centrifuged at 40,000 x g and 100,000 x g for 
4 hours. Mice, previously treated with lipid, were given 5.0 mg doses 
of the supernatant obtained from the top one-third of the centrifuge 
tube. From the results presented in Table 15 it can be seen that the 
percent recovery was greater at the slower speed. However, there was 
no correlation between centrifugation speed and tolerogenic capacity.
To determine the effect of duration of centrifugation, antigen 
preparations were centrifuged at 100,000 x g for 2.5 and 4 hours. No 
correlation existed between duration of centrifugation and tolerogenic
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TABLE 15
EFFECT OF SPEED OF CENTRIFUGATION ON PERCENT RECOVERY 
AND TOLEROGENIC CAPACITY OF 5.0 mg 
OF HUMAN GAMMA GLOBULIN
Centrifugation x g
100,000 100,000 40,000
Percent Recovery 56.6 64.7 80.0
Tolerogenic Capacity 3.2* (7)b 0.7 (8) 1.8 (13)
Controls^ 5.3 (3) 3.0 (5) 5.6 (8)
^ean logg titer at two weeks. 
^Number of animals tested.
Control animals received saline rather than sHGG prior to 
immunization with aggHGG.
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ability of the sHGG (Table 16). Percent recovery was slightly higher, 
in most cases, with the shorter centrifugation period.
In the first experiment of the tolerance induction series the 
sHGG was prepared by centrifuging at 40,000 x g for 4 hours with an 
angle head rotor. The yield was extremely low (36.5%). Also, it was 
impossible to control the monomeric purity of the sHGG since antigen 
which sedimented on the walls of the tubes during centrifugation could 
wash off into the supernatant after cessation of centrifugation. For 
these reasons a swinging bucket rotor was used for all subsequent prep­
arations of sHGG.
The Effect of Lipid on Tolerance Induction 
by Several Doses of sHGG
Single injections of various concentrations of sHGG were given 
to lipid-treated mice to determine whether a dose which was normally 
antigenic would become tolerogenic when the RES was depressed. The re­
sults of these experiments are shown in Figures 3 through 17, which will 
be discussed later. In each of these figures, EX represents the lipid- 
treated or experimental group, and TC and IC denote the tolerance con­
trol and immunization control groups, respectively. Each dot represents 
the passive hemagglutination titer of an animal at the specified time. 
The horizontal line in the middle of each vertical bar designates the 
mean hemagglutination titer of all animals in that group. The upper 
and lower horizontal lines indicate the limits of one standard deviation 
above and below this mean. In certain instances the lower limit of one 
standard deviation was less than zero in which case the vertical line 
stops at zero.
TABLE 16
EFFECT OF DURATION OF CENTRIFUGATION ON PERCENT RECOVERY 
AND TOLEROGENIC CAPACITY OF 5.0 mg 
OF HUMAN GAMMA GLOBULIN
Duration of Centrifugation (hours)
2.5 2.5 2.5 2.5 4 4
Percent Recovery 59.4 71.7 75.8 81.0 56.6 64.7
Tolerogenic Capacity 1.6^ (8)b 3.5 (13) 4.0 (6) 3.6 (13) 3.2 (7) 0.7 (8) <5
Controls^ 7.4 (7) 6.7 (7) 6.6 (5) 4.8 (26) 5.3 (3) 3.0 (5)
^ean logg titer at two weeks.
b...Number of animals tested.
'Control animals received saline rather than sHGG prior to immunization with aggHGG.
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In evaluating the data represented in Figures 3 through 17, it 
should be borne in mind that the unsensitized SRBC control titrations 
often had log^ titers of one. Therefore, test titers of one may not be 
significant in all instances. Further, titers determined on different 
days sometimes varied ± one logg unit. Similar variations with this 
assay have been reported by Unanue and Askonas (1968).
Low doses of sHGG. Two experiments were performed employing a 
0.5 mg dose of sHGG. The results of one of these experiments are pre­
sented in Figure 3. At 2 and 3 weeks following challenge, approximately 
half of the lipid-treated animals had somewhat lower titers than those 
of the control groups and 4 appeared to be tolerant or hyporesponsive.
By 4 weeks, however, all lipid-treated animals had titers similar to 
those of the tolerance controls. No marked difference was noticed in 
titers of the tolerance and immunization control animals at 2 and 3 
weeks post-challenge. At 4 weeks, approximately half of the immuniza­
tion controls had titers ranging from 8 to 10 logg units.
A second experiment employing 0.5 mg sHGG was terminated fol­
lowing the 2 weeks post-challenge titration since there was no differ­
ence in titers of the 3 groups. Similar findings were observed when a
0.1 mg dose of sHGG was used.
For comparative purposes, an additional experiment was performed 
using C57BL/6 mice rather than the BALB/c strain since the former strain 
is much more susceptible to tolerance induction than is the latter 
(Golub and Weigle, 1969). Mice were divided into 5 groups. Two groups 
were treated with lipid. One of these groups was then injected with



























! • • • ###
1# #T
1 *  * •
# #
WEEKS AFTER IMMUNIZATION
Figure 3. Effect of ethyl stearate-methyl palmitate treat­
ment on tolerance induction in BALB/c mice by 0.5 mg of sHGG. EX - 
experimental or lipid-treated group; TC - tolerance controls, IC - 
immunization controls-
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HGG. Two groups were used as tolerance controls for the 2 preparations 
of HGG and the last group served as immunization controls. The response 
of the animals which received sHGG or uncentrifuged HGG are presented 
in Figures 4 and 5, respectively. At 2 and 3 weeks post-challenge most 
of the lipid-treated animals and approximately half of the tolerance 
controls which had received sHGG appeared to be unresponsive or hypore­
sponsive (Figure 4). At 4 and 5 weeks after immunization 5 of the 8 
lipid-treated animals were still hyporesponsive.
Most of the mice which received uncentrifuged HGG appeared to 
be hyporesponsive 2 weeks following immunization. The titers of all of 
these mice increased gradually during the next 3 weeks and by 5 weeks 
post-challenge none was unresponsive and most had titers of 3 logg units 
or more. The surprising finding was that the titers of the tolerance 
controls failed to increase at the same rate as those of the immuniza­
tion controls. At 5 weeks post-challenge 3 of the 6 tolerance control 
mice had titers from 1 to 2 logg units less than those of the lowest 
immunization control animals.
Intermediate dose of sHGG. A dose of 1.0 mg of sHGG severely 
depressed the immune response of a majority of both the experimental 
and tolerance control animals (Figure 6). This depression was evident 
throughout the test period from 3 to 6 weeks post-challenge. Tolerance, 
in this case, was apparently due to the dose of sHGG used rather than to 
any influence of the lipid.
A second experiment employing the same dose of sHGG gave similar 
results. Titers of the experimental and tolerance control groups were 
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Figure 4. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
C57BL/6 mice by 0.5 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
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Figure 5. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
C57BL/6 mice by 0.5 mg of native (uncentrifuged) HGG.. EX - experimental or lipid-treated group;
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Figure 6. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 1.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
IC - immunization controls.
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experiment.
High doses of sHGG. Six experiments were carried out using 5.0 
mg sHGG for tolerance induction. They will be reported in the order in 
which they were performed. The results of the first experiment (Figure 
7) were very similar to those obtained with 1.0 mg sHGG in that the 
titer means and ranges were remarkably alike for the experimental and 
tolerance control groups. Further, the mean titers of these 2 groups 
were not significantly different from those of the immunization controls.
The second experiment employing a 5.0 mg dose of sHGG gave re­
markably different results (Figure 8). A significant proportion of the 
lipid-treated mice were tolerant or hyporesponsive, as compared to both 
control groups, throughout the experiment. Several of the tolerance 
control mice had titers somewhat lower than those of the immunization 
control animals at 2 and 3 weeks post-challenge. By 4 weeks the 
tolerance control titers approached those of the immunization controls 
and by 5 weeks the titers of both control groups were identical in range.
In the third experiment, using the same dose of sHGG, the lipid-
treated animals again appeared to be immunologically depressed, when 
compared to the immunization controls, throughout the 5 week post-chal­
lenge period (Figure 9). However, the tolerance controls varied greatly 
in their response with a significant number also displaying hyporespon- 
siveness and only a few having titers within the range of the immuniza­
tion control group at the 3, 4 and 5 weeks post-challenge periods.
The results of the fourth experiment (Figure 10) resemble some­
what those of the first experiment (Figure 7) in that no real difference
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Figure 7. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 5.0 mg sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
IC - immunization controls.









Figure 8. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 5.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
IC — immunization controls.











Figure 9. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 5.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
IC - immunization controls.








Figure 10. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 5.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
IC - immunization controls.
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Approximately half of the animals in each of these groups were hypore­
sponsive up to 4 weeks post-challenge. The wide variation in the re­
sponse observed frequently in tolerance control animals was again evi­
dent throughout this experiment. A similar variation in response was 
seen among the experimental animals at the 2 and 3 week periods. This 
trend would probably have extended over the 4 and 5 weeks period but 
this is not evident from an examination of Figure 10 due to the reduced 
number of experimental animals.
The lipid-treated animals in the fifth experiment again dis­
played a wide variation in response and only 2 or 3 were hyporesponsive 
(Figure 11). This hyporesponsiveness did, however, persist throughout 
the experiment. Some variation in response was also noted in the toler­
ance control group, although this was not as great as that seen in some 
of the previous experiments. Two tolerance control mice which appeared 
to be hyporesponsive at 2 weeks post-challenge did not maintain this 
state upon subsequent testing. The majority of the tolerance and immuni­
zation control animals had titers of the same order of magnitude at 2 
and 3 weeks post-challenge. At 4 and 5 weeks post-challenge the mean 
titers of the immunization controls increased approximately 2 log^ units, 
whereas there was no significant change in the titers of most of the 
tolerance control animals.
The results of the sixth experiment, presented in Figure 12, 
are quite similar to those obtained in the second experiment (Figure 8) 
and demonstrate that lipid treatment can, in some cases, enhance the in­
duction of tolerance in BALB/c mice. Examination of Figure 12 reveals 








Figure 11. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 5.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls:
IC - immunization controls.




























Figure 12. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 5.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
IC - immunization controls.
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lower than those of either control group throughout the experiment. The 
titers of some of the experimental mice increased slightly over the 
course of the experiment but they seldom exceeded the lowest titers of 
the tolerance control animals. In general, the titers of the majority 
of the tolerance control mice were intermediate between those of the 
experimental and immunization control animals. The results of this 
series of experiments, employing 5.0 mg doses of sHGG, have been com­
piled in Table 17.
The experimental animals in the previous studies were injected 
with an emulsion containing both ethyl stearate and methyl palmitate.
It was deemed of interest to determine if either of these lipids, given 
separately, would enhance tolerance induction to sHGG to a greater ex­
tent than did the two lipids given in combination. For this purpose, 
mice were divided into 5 groups. One group received ethyl stearate, 
another received methyl palmitate and a third group received both lipids. 
The remaining 2 groups were used as tolerance and immunization controls. 
The experiment was performed as described previously and all experimental 
and tolerance control animals received 5.0 mg of the same preparation of 
sHGG. The response of these animals at 2 and 5 weeks after immunization 
is shown in Figure 13. Once again, a wide variation was seen in the 
titers of all 3 groups of experimental animals. Although a few animals 
in each treatment group appeared to be hyporesponsive at 2 weeks, this 
state rarely persisted. The mean titer of the ethyl stearate-treated 
mice was somewhat lower than those of the other two experimental groups. 
At 5 weeks, the methyl palmitate-treated mice had a mean titer inter­
mediate between the ethyl stearate and the ethyl stearate-methyl
TABLE 17
THE EFFECT OF ETHYL STEARATE-METHYL PALMITATE TREATMENT ON THE 
INDUCTION OF TOLERANCE IN BALB/c MICE BY 5.0 mg 







Percentage of Mice in Each Group Having 
Log2 Hemagglutination Titers of :
Mean
Log2
0-2 3-5 6—8 z 9
Titer
2 EX 60 60 27 13 2.5
TC 70 21 54 23 2 4.2
IC 61 3 43 52 2 5.4
3 EX 64 41 59 2.8
TC 67 13 74 13 4.1
IC 57 7 44 49 5.2
4 EX 60 38 55 7 3.2
TC 63 10 57 33 4.7
IC 58 5 41 40 14 6.0
5 EX 48 46 33 21 3.1
TC 48 17 42 39 2 4.5
IC 33 15 70 15 7.2
ooLn
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Figure 13. Effect of ethyl stearate and methyl palmitate, given 
separately and in combination, on tolerance induction in BALB/c mice by 
5.0 mg of sHGG. ES - ethyl stearate-treated mice; MP - methyl palmitate 
treated mice; ES-MP - mice treated with both lipids; TC - tolerance con­
trols; IC - immunization controls.
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palmitate-treated groups. The tolerance control animals had generally 
higher titers at 2 weeks post-challenge than had been seen in previous 
experiments. Because of the wide range in titers in each of the experi­
mental groups and because the limits of ranges were similar for each 
group, it is impossible to make a definite statement with regard to the 
relative effectiveness of the 3 lipid preparations in promoting hypore­
sponsiveness. The data do suggest, however, that the proportion of 
antigen in monomeric form in the sHGG preparation used in this experi­
ment was less than that in preparations used in the preceding experi­
ments. This is evidenced by the fact that the titers of mice treated 
with the combination of lipids were generally higher in this experiment 
than in the preceding ones, particularly at 5 weeks post-immunization.
The influence of ethyl stearate-methyl palmitate treatment on 
the induction of tolerance to 10.0 mg of sHGG was investigated in 4 
separate experiments. The results of the first experiment of this series 
are presented in Figure 14. The majority of the lipid-treated animals 
and the tolerance controls were hyporesponsive throughout the experiment. 
There was no significant difference in the degree of hyporesponsiveness 
as evidenced by the similarity in the mean hemagglutination titers of 
the 2 groups. However, 2 of the tolerance control mice were not hypore­
sponsive but, rather, responded like the immunization controls. The 
immunization control animals, in general, had higher titers than the 
other 2 groups. This was particularly evident at 4 and 5 weeks post­
immunization.
The results of the second experiment in this series were sur­





















Figure 14. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 10.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
IC - immunization controls.








Figure 15. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 10.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
IG - immunization controls.
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the tolerance control group had a larger proportion of hyporesponsive 
animals than did the lipid-treated group. The possibility that these 2 
groups were inadvertently mixed cannot be excluded. The hyporesponders 
in each group maintained this state throughout the duration of the experi­
ment. The experimental animals, as noted in previous experiments, ex­
hibited a wide range of titers.
A wide range of titers was also seen in the lipid-treated ani­
mals in the third experiment in which a 10.0 mg dose of sHGG was employed 
(Figure 16). Only 1, or possibly 2, of these mice were hyporesponsive. 
None of the tolerance control animals was hyporesponsive. Titers of the 
experimental and tolerance control mice tended to decrease somewhat from 
the second to the fifth week after immunization. This probably is a re­
flection of the variation in the sensitivity of hemagglutination titra­
tions performed on different days rather than a real decrease in the 
titers of individual animals. The titrations may have been somewhat 
more sensitive than usual at 2 weeks and less sensitive at 5 weeks.
The results of the final experiment in this series are shown 
in Figure 17. All but 1 or 2 of the lipid-treated animals were signi­
ficantly hyporesponsive throughout the experiment. The titers of the 
tolerance control group varied over a range of 5 logg units, however, 
the titers of most of these animals were intermediate between the experi­
mental and the immunization control mice. Only one of the tolerance 
controls appeared to be as hyporesponsive as the lipid-treated mice.
Table 18 contains a summary of the results of all of the ex­
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Figure 16. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 10.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
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Figure 17. Effect of ethyl stearate-methyl palmitate treatment on tolerance induction in
BALB/c mice by 10.0 mg of sHGG. EX - experimental or lipid-treated group; TC - tolerance controls;
10 - immunization controls.
TABLE 18
THE EFFECT OF ETHYL STEARATE-METHYL PALMITATE TREATMENT ON THE 
INDUCTION OF TOLERANCE IN BALB/c MICE BY 10.0 mg 













0-2 3-5 6—8 > 9
2 EX 27 67 18 15 2.2
TC 26 50 25 25 3.5
IC 20 10 20 65 5 3.7
3 EX 26 77 8 15 1.7
TC 27 45 24 31 3.0
IC 19 15 32 53 5.4
4 EX 26 77 15 8 1.6
TC 26 41 33 26 3.0
IC 19 21 58 21 7.3
5 EX 23 74 26 1.6
TC 26 42 50 8 2.8
IC 19 10 80 10 6.7
^EX - experimental or lipid-treated group ; TC - tolerance controls; IC - immunization controls
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Hemagglutination-Enhancement Effect of BSA
The hemagglutination titers of the immunization control animals 
in tolerance induction experiments conducted early in this study were 
considerably lower than had been expected. The titrations were repeated 
substituting BSA for the PBSG diluent to detect the possible presence 
of an incomplete antibody. Without exception, the BSA titer of each 
animal was markedly higher than its PBSG counterpart. Therefore, in all 
subsequent tolerance induction experiments both the PBSG and BSA hemag­
glutination titers were determined for each animal. The results of a 
comparison of mean PBSG and BSA titers for 196 BALB/c mice used in the 
5.0 mg dose tolerance induction experiments are presented in Figure 18.
It is obvious that the mean BSA titers were significantly higher than 
the mean PBSG titers in both the experimental and the two control groups 
at each week tested. The difference in the two titers was greatest in 
the experimental mice and least in the immunization control animals. 
Further, it is evident that the mean BSA titers varied no more than 1.5 
logg units among the 3 test groups, whereas, a significant variation 
was noted in the corresponding PBSG titers. In fact, the sera of sever­
al mice which had high hemagglutination titers in the BSA assay were 
completely negative when titrated in the PBSG diluent. For lack of a 
more precise term at present, the substance responsible for the BSA- 
enhancement effect will subsequently be referred to as "BSA-detectable 
antibody" (BSA-DAB).
Several attempts were made to characterize BSA-DAB. To study 
its heat stability, the serum from each animal in the three test groups 
was pooled. The serum pools were divided in half and one-half was heated
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in a water bath at 56C for 30 minutes while the other half of each pool 
was refrigerated (4C). The BSA and PBSG titers of each serum pool, 
heated and unheated, were determined. The results of three such experi­
ments are presented in Table 19. Heating did not significantly alter 
the PBSG titer. BSA titers, however, were drastically reduced in the 
heated serum pools, the titer loss ranging from 2 to 8 logg units. In 
all cases, the BSA titer of the heated pooled sera equaled or approxi­
mated the PBSG titer of the corresponding unheated serum pool.
To test the affect of prior absorption of mouse serum with HGG 
on hemagglutination titers, individual sera from the 3 test groups were 
pooled and a 0.2 ml aliquot from each serum pool was added to equal 
volumes of both HGG (0.05 mg/0.2 ml) and saline. The absorption mix­
tures were incubated at room temperature for 2 hours and then refrig­
erated overnight. The tubes were then centrifuged at 1,500 rpm for 5 
minutes. A precipitate was visible in those tubes containing HGG. The 
supernatant was removed from each tube and titrated in both PBSG and 
BSA. From the results presented in Table 20 it can be seen that both 
BSA-DAB and the PBSG anti-HGG can be completely removed from mouse sera 
by absorption with 0.05 mg of HGG.
Similar observations were made when hemagglutination assays 
were performed in the presence of excess HGG. A 20 mg/ml solution of 
HGG was diluted 1:10 and 1:100 in PBSG or in BSA to give final concen­
trations of 2 mg/ml (0.05 mg/well) and 0.2 mg/ml (0.005 mg/well), re­
spectively. Both the PBSG and BSA titers of all 3 test groups were 
completely inhibited by a 2 mg/ml concentration of HGG (Table 21). The 
BSA and PBSG titers of the experimental group were also abolished by the
TABLE 19
EFFECT OF TEMPERATURE ON HEMAGGLUTINATION 






Mean Titer of Individuals 
Within Pool Pooled Sera
PBSG BSA
PBSG BSA
Unheated Heated^ Unheated Heated
1 EX 2.9 10.6 3.0 2.0 9.0 3.0
TC 5.3 10.2 4.0 4.0 9.0 5.0
IC 6.6 10.2 5.0 5.0 10.0 6.0
2 EX 3.1 10.4 3.0 2.0 9.0 3.0
TC 5.3 10.0 4.0 3.0 9.0 5.0
IC 8.3 12.3 6.5 6.0 10.5 8.0
3 EX 2.1 8.3 4.0 2.0 11.0 3.0
TC 4.4 8.5 6.0 4.0 11.0 6.0
IC 8.1 10.5 8.0 8.0 12.0 10.0
VD
EX - experimental group; TC - tolerance control group; IC - immunization control group.
Heated at 56C for 30 minutes.
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TABLE 20
EFFECT OF ABSORPTION WITH HGG ON HEMAGGLUTINATION 
TITER IN PBSG OR BSA DILUENTS
Serum Absorption
Log^ Hemagglutination Titer
Pool^ Material PBSG BSA
EX Saline 1 5
EX HGG 0 0
TC Saline 2 6
TC HGG 0 0
IC Saline 4 7
IC HGG 0 0
Control^ Saline 4 4
Control HGG 0 0
- experimental group; TC 
IC - immunization control group.
^Commercial rabbit anti-HGG.
- tolerance control group;
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TABLE 21
HEMAGGLUTINATION INHIBITION EFFECT OF EXCESS HGG 






EX^ TC^ IC^ Control^
PBSG 0 2 3 5 5
0.2 1 2 2 0
2.0 1 1 1 0
BSA 0 5 7 8 5
0.2 1 2 2 0
2.0 1 1 1 0
Pooled serum of experimental animals.
^Pooled serum of tolerance control animals. 
^Tooled serum of immunization control animals.
Commercial rabbit anti-HGG.
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0.2 mg/ml concentration of HGG and both titers of the tolerance and im­
munization control groups were severely reduced. Titers of one logg 
unit were not considered significant, since the unsensitized cell con­
trols had similar titers.
It was of interest to know if BSA-DAB was specific for HGG.
For this purpose, mouse gamma globulin (MGG) was conjugated to SRBC em­
ploying the same procedure as that with HGG. A concentration of 2 mg 
MGG/ml was used since this has been found to give the highest hemaggluti­
nation titers (Kramer, 1970). Titrations were performed as described 
previously, using both PBSG and BSA as diluents. The results, presented 
in Table 22, demonstrated that BSA-DAB reacts with both HGG and MGG. In 
fact, higher titers were observed with MGG than with HGG. The differ­
ence in titers ranged from 1-3 logg units. The anti-HGG antibody de­
tected with the PBSG diluent did not cross react with MGG. The logg 
anti-MGG titers of one for the experimental and tolerance control groups 
were not considered to be significant as the corresponding unsensitized 
cell controls also had titers of one, indicative of a non-specific re­
action with the SRBC. Further evidence for the cross reactive nature 
of BSA-DAB was the observation that the reaction with MGG could be in­
hibited when the titration was carried out in the presence of HGG 
(Table 22).
During the course of these investigations it was noticed that 
the BSA titer of many sera decreased as the duration of storage increased 
and also decreased after multiple freeze-thawing. Upon completion of the 
final tolerance induction experiment the remaining individual sera were 
frozen and stored for varying periods of time. In addition, these sera
TABLE 22
CROSS REACTIVITY BETWEEN MGG AND ANTI-HGG PRODUCED
IN BALB/c MICE
Logg Hemagglutination Titer Specific for :
Diluent MGG HGG
EX^ TC^ c d IC Control EX TC IC Control^
PBSG 1 1 9 2 3 5 5






Experimental group pooled sera. 
^Tolerance control group pooled sera. 




were subjected to a varying number of freeze-thaw cycles. Titrations 
were performed in PBSG and BSA after each of these test procedures. 
Examination of Table 23 reveals that PBSG titers were not affected by 
prolonged storage or multiple freeze-thawing of serum. The BSA titers 
of the immunization control animals were similarly unaffected by these 
procedures. However, BSA titers of many of the experimental and toler­
ance control animals were markedly reduced. Multiple freeze-thawing 
appeared to have a more profound effect on the tolerance control mice 
than did prolonged storage since after 40 days of storage none of the 
4 sera tested had decreased in titer by 3 or more logg hemagglutination 
units. Both prolonged storage and multiple freeze-thawing appeared to 
account for the decreased BSA titers in the experimental mice. These 
results are merely suggestive. Before any definite statement can be 
made a much larger number of sera would have to be tested.
TABLE 23
EFFECT OF MULTIPLE FREEZE-THAWING AND DURATION OF STORAGE 
AT -IOC ON HEMAGGLUTINATION TITERS 









EX^ TC^ Ic": EX TC IC
1 7 0/2^ 0/4 0/2 0/2 0/4 0/2
2 11 0/4 0/4 0/2 4/4 2/4 0/2
3 18 0/3 0/4 0/2 2/3 3/4 0/2
4 23 2/4 0/4 0/2 4/4 3/4 0/2
1 40 0/4 0/4 0/1 3/4 0/4 0/1
oLO
Experimental or lip id-treated, animals.
Tolerance controls.
'Immunization controls.
Number of mice with a titer decrease of 3 or more log^ hemagglutination units/total tested.
CHAPTER IV
DISCUSSION
The primary aim of this investigation was to determine whether 
RES depression would enhance the induction of tolerance to sHGG in BALB/c 
mice. Two lipids, ethyl stearate and methyl palmitate, were employed 
as RES depressants. The extent and duration of RES depression was deter­
mined by measuring the intravascular clearance rate of colloidal carbon. 
In these studies the mice were routinely anesthetized with sodium penta- 
barbital for ease in handling. It was found that anesthesia did not 
alter the clearance rates of normal animals (Table 2).
Ethyl stearate, obtained from two sources, was evaluated as to 
the dose required for maximum RES depression, the duration of the induced 
depression and the toxicity for mice. The two lipid preparations from 
both sources were nearly identical in their depressant activity. Doses 
ranging from 20 - 80 mg were equally effective in producing a significant 
depression of RES function. Higher doses caused an even more profound 
depression but were extremely toxic. Percent survival for 60 and 80 mg 
doses were 100 and 70 percent, respectively. Maximum RES depression 
occurred 24 hours following a 60 mg dose of ethyl stearate. Thereafter, 
the extent of the depression gradually lessened and normal RES function 
was regained within 4 to 7 days. These findings are in accord with those 
of Stuart, £t (1960) and Stuart and Cooper (1962). Marked and
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diffuse necrosis of splenic white pulp was observed within 24 hours 
after lipid administration. Regeneration was evident within 4 days.
This supports the belief of Stuart and Cooper (1962) that ethyl stearate 
exerts its RES depressive effect through a cytotoxic mechanism. These 
investigators reported that the Kupffer cells were the primary target of 
ethyl stearate toxicity. However, in the present study no liver patho­
logy was detected. This discrepancy could be due to the use of different 
doses and source of lipid by these workers. Probably of more importance, 
a different strain of mice was used in their investigation. Prosnitz, 
et al. (1969) have shown that animal species and even strains differ in 
their response to certain lipids.
Methyl palmitate preparations obtained from two suppliers were 
evaluated in the same manner as that used with ethyl stearate. The 
preparation obtained from Nutritional Biochemicals Corp., while effec­
tive in depressing RES activity, was toxic at doses as low as 20 mg.
The methyl palmitate supplied by Applied Science Laboratories was much 
less toxic. Doses of this lipid ranging from 15 - 45 mg induced RES 
depression. The 15 mg dose only mildly impaired RES function, whereas 
the 25 mg and 35 mg doses caused marked depression. The most profound 
impairment was produced by a 45 mg dose. Mice treated with 45 mg of 
methyl palmitate were maximally depressed 24 hours later, as evidenced 
by their mean carbon half-time of 97.1 minutes which was in marked con­
trast to the 17.4 minute mean half-time of the controls. Normal RES 
function was regained within 4 to 10 days following lipid treatment.
Two successive 25 mg doses of methyl palmitate, given 4 days apart, did 
not increase the duration of RES depression. These results do not agree
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entirely with those obtained by other investigators using methyl palmi­
tate from the same supplier (DiLuzio and Wooles, 1964; DiLuzio and 
Blickens, 1966). These investigators obtained maximum RES depression in 
C57BL/6 mice with a 35 mg dose of methyl palmitate. They observed marked 
impairment over a period of 5 hours to 7 days following lipid treatment 
with the most profound depression occurring at 48 hours. Normal function 
was regained in 12 to 17 days. It appears, therefore, that C57BL/6 mice 
respond to methyl palmitate treatment in a different manner than do 
BALB/c mice. This is further substantiated by the fact that these and 
other investigators (Ohbuchi, 1968) found no histological evidence of 
hepatic or splenic pathology associated with methyl palmitate treatment, 
whereas in the present study all mice examined exhibited marked splenic 
necrosis. In fact, the splenic pathology of the methyl palmitate-treated 
mice was almost identical to that seen in mice treated with ethyl stea­
rate, the major difference being that regeneration began somewhat earlier 
following methyl palmitate treatment. This might explain, in part, the 
shorter duration of RES depression in BALB/c mice. There are other fac­
tors, however, which influence the response of mice to lipid treatment. 
For example, the particle size of the emulsified lipid determines its 
organ distribution. DiLuzio and Wooles (1964) prepared emulsions of 
methyl palmitate by mechanical agitation. Particle size ranged from 
3 - 15 y. This preparation was highly toxic since the larger particles 
were trapped in the lung resulting in the formation of pulmonary emboli, 
edema and finally death. When emulsions were prepared by sonication, 
the particle size ranged from 1 - 6 y (DiLuzio and Blickens, 1966).
This preparation was much less toxic and did not cause any increase in
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lung weight. The methyl palmitate emulsion used in the present study 
was also prepared by sonication. Most particles were within the range 
of 3 - 8 y although a small proportion were somewhat larger. This dif­
ference in particle size of the lipid emulsions could provide one expla­
nation for the different responses observed in C57BL/6 and BALB/c mice.
To summarize, ethyl stearate and methyl palmitate are quite 
similar in their action on the RES. Both depress RES function maximally 
at 24 hours, although methyl palmitate exerts a more profound impairment 
at this time, and the duration of their effect is approximately the same. 
The unusually long mean carbon half-time seen at 7 days after ethyl 
stearate treatment (Table 6) resulted from the inclusion of one animal 
which was severely depressed (T/2 - 231.5 minutes). Half-times of the 
other mice ranged from 13.5 to 91.2 minutes. It should be noted that in 
the summarizing procedures required in statistical analyses, interest 
becomes focused upon population characteristics, such as mean values, 
rather than upon the behavior of individual animals. The peculiar re­
sponse of specific animals, such as those with extremely long half-times 
(T/2 - «>) which were excluded from the mean comparisons, may be of par­
ticular interest since it may indicate a subpopulation which is extremely 
sensitive to lipid-induced RES depression. Occasionally an animal was 
observed to have a half-time less than infinity but still markedly pro­
longed as compared with those of other mice in the same group. These 
animals were included in the statistical analysis since their number was 
not sufficient to allow rejection of the normality assumption. Such 
animals may also be members of the distinctive subpopulation rather than 
the chance observing of an extreme from a normal distribution. They,
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together with the excluded animals, provide a basis for speculation re­
garding the possible existance of a subpopulation of extremely lipid- 
sensitive animals.
It was thought that ethyl stearate and methyl palmitate, ad­
ministered together, might produce a more severe and/or prolonged depres­
sion of the RES than that caused by either lipid given singly, since it 
is generally believed that these two lipids exert their influence on the 
RES by different mechanisms. Mice treated with 30 mg of ethyl stearate 
plus 22.5 mg of methyl palmitate exhibited RES depression very similar 
in extent and duration to that of mice given the lipids separately. 
Further, the splenic pathology of these mice was similar to those treated 
with methyl palmitate. Fat was observed in the splenic histiocytes in 
one of these animals 4 days following treatment. Fat was not evident at 
either 1 or 4 days post-lipid injection in the spleens or livers of any 
of the other animals treated with either lipid alone or in combination. 
The absence of fat in these organs at these times is probably a reflec­
tion of the efficiency of the RES in metabolizing and degrading this 
material. Prosnitz, et al. (1969) found the livers of mice treated with 
ethyl palmitate to be extensively infiltrated with fat one hour after 
injection. However, the lipid had virtually disappeared within the next 
hour. The livers and spleens of methyl palmitate-treated mice did not 
increase in weight at any time from 1 hour to 17 days after lipid ad­
ministration (DiLuzio and Blickens, 1966) indicating the absence of a 
large or prolonged deposition of fat in these organs.
Treatment of C57BL/6 mice with the ethyl stearate-methyl palmi­
tate emulsion indicated that this strain is considerably more susceptible
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to the RES depressive influence of these lipids than are BALB/c mice.
The mean half-times, 24 hours after lipid administration, for C57BL/6 
and BALB/c mice were 305.5 minutes and 69.5 minutes, respectively. It 
also appeared that normal, untreated C57BL/6 mice are more efficient in 
removing colloidal carbon from the circulation than are BALB/c mice.
The mean half-time for the C57BL/6 controls was 7.1 minutes, whereas 
that for the BALB/c controls was 14.1 minutes. A comparison of RES de­
pression in C57BL/6 mice produced by methyl palmitate (DiLuzio and 
Blickens, 1966) and by the ethyl stearate-methyl palmitate emulsion 
(this study) suggests that the combination of lipids is far more effec­
tive than methyl palmitate alone. Mean half-times 24 hours after injec­
tion were 305.5 minutes for ethyl stearate-methyl palmitate-treated mice 
and 54.4 minutes for mice treated with only methyl palmitate. Mean 
half-times for control mice were similar in both studies (7.1 and 9.6 
minutes). Although caution should be exercised when comparing results 
from different laboratories, if this difference is, indeed, a real and 
significant one, it can be concluded that either the two lipids in com­
bination or ethyl stearate in relatively low dosage (30 mg) are more 
effective RES inhibitors for C57BL/6 mice than is methyl palmitate alone.
Several attempts were made to induce RES depression in rabbits 
with either ethyl stearate or methyl palmitate. All were unsuccessful 
and it was later learned that both rabbits and dogs are refractory to 
lipid-induced RES depression (DiLuzio, 1969).
Throughout the RES depression studies, a wide variation in car­
bon half-times was observed in both lipid-treated animals and, to a 
lesser extent, in control mice. Inherent differences in the
110
physiological function of individual animals would undoubtedly account 
for part of this variation. In the case of lipid-treated animals, vari­
ation would also result if an animal failed to receive a full dose of 
lipid. Within a given control group, variation in clearance rates of 
individual animals was not as great as that in the corresponding test 
mice although an occasional animal with an exceptionally short or long 
half-time was encountered. The mean half-time for 245 control animals 
used in this study was 15.3 minutes. Individual half-times ranged from 
2.4 - 60.2 minutes. However, only 22.8 percent of the control mice had 
half-times longer than 20 minutes and 7.7 percent were over 30 minutes. 
Animals suffering from a subclinical or chronic infection tend to have 
hyperactive RE systems and would, therefore, have shorter carbon half- 
times. Obviously unhealthy animals were excluded from the study. Pro­
longed half-times could result from metabolic disorders affecting he­
patic function. More perplexing was the occasional occurrence of signi­
ficantly depressed RES function in nearly all animals in a given control 
group. This could be explained by alterations in environmental condi­
tions such as temperature and humidity changes, or by fluctuations in 
food intake, or cyclic variations in physiological function. Whatever 
the causes of this variation, its existence emphasizes the necessity for 
concomitant controls for experiments performed at different times.
Soluble HGG in low doses (0.1 mg and 0.5 mg) failed to induce 
a persistent tolerant or hyporesponsive state in BALB/c mice pre-treated 
with the ethyl stearate-methyl palmitate emulsion. However, both lipid 
treatment and sHGG influenced the immune response of these animals. In 
Figure 3 it can be seen that the hemagglutination titers of a majority
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of the tolerance control animals ranged from 3 - 6  logg units throughout 
the course of the experiment. This level was somewhat less than the 
titers of most of the immunization control mice 4 weeks post-challenge. 
Therefore, it can be concluded that the prior injection of sHGG limited 
the capacity of these animals to respond maximally to challenge with 
aggHGG, a highly immunogenic material. The fact that the lipid-treated 
animals had even lower titers initially than did the tolerance control 
mice strongly suggests that the lipids, as well as the sHGG, acted to 
impair the immune response of these animals and, further, that the in­
hibitory effect of the two materials was additive. A possible explana­
tion could be based upon the fact that soluble materials are not effici­
ently phagocytized by the RES. Therefore, only a portion of the injected 
dose of sHGG was phagocytized and processed by the tolerance control 
mice. The lipid-treated mice, with depressed RES function, would re­
quire a longer time to engulf and/or process an amount of sHGG equivalent 
to that handled by the tolerance control mice. The problem with this 
hypothesis is that one would expect that even the small amount of sHGG 
processed would prime the animals for a secondary response upon challenge 
with aggHGG. It has been demonstrated with other protein antigens that 
the injection of antigen in quantities too small to elicit a primary re­
sponse can prime an animal for an anamnestic response. Perhaps, in the 
case of sHGG, a significant proportion of the immunocompetent cells are 
rendered tolerant resulting in the development of fewer memory cells.
Upon challenge, then, the remaining immunocompetent cells would respond 
normally but the total amount of antibody synthesized would be less than 
normal due to the reduced size of this cell population.
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A 0.5 mg dose of sHGG induced tolerance or hyporesponslveness 
in approximately half of the lipid-treated C57BL/6 mice (Figure 4).
This substantiates prior observations that the C57BL/6 strain is less 
refractory to tolerance induction than are BALB/c mice (Golub and Weigle, 
1969). Four of the 6 tolerance control animals failed to respond as
rapidly or to the same degree to challenge with aggHGG as did the immuni­
zation control mice. The observation that lipid-induced RES depression 
was more profound in C57BL/6 mice than in BALB/c mice could explain why 
a significant number of the former strain was rendered tolerant to 0.5 
mg sHGG, whereas, the latter was not. The percentage of tolerant 
C57BL/6 mice was less than expected. Golub and Weigle (1969) reported
100 percent tolerance in normal C57BL/6 mice to doses of sHGG ranging
from 0.1 - 10.0 mg. Moreover, these investigators prepared sHGG by 
centrifugation at 20,000 x g for 30 minutes, conditions much less strin­
gent than those employed in the present study. It would, therefore, be 
expected that their preparation would contain less monomeric antigen 
and, thus, be more immunogenic. However, certain differences in experi­
mental procedure might account for the apparent quantitative differences 
in these two investigations. Golub and Weigle (1969) evaluated toler­
ance by immune elimination of labeled HGG rather than by passive hemag­
glutination. Although these two methods of measuring an immune response 
generally agree (Frei, e^ ̂ . , 1968), positive hemagglutination titers 
have been found in neonatal rabbits tolerant to HGG as determined by 
immune elimination (Weigle and Fudenberg, 1966). Another variable was 
the time at which tolerance was determined. Golub and Weigle (1969) 
tested their animals for immune elimination only once, at 1 week
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post-challenge. A longer interval between challenge and assay of the 
immune response might have revealed some responsive animals.
A 0.5 mg dose of uncentrifuged, native HGG failed to induce 
tolerance in lipid-treated C57BL/6 mice (Figure 5). At 2 weeks post­
challenge both the experimental and tolerance control animals appeared 
to be hyporesponsive. However, both groups of animals displayed titers 
which increased gradually with time. Throughout the experiment both 
groups had remarkably similar titers and most were significantly lower 
than the titers of the corresponding immunization control animals. It 
might be expected that the lipid-treated mice would exhibit a delayed 
or limited response but why this also occurred in the tolerance control 
animals is perplexing and no ready explanation is available. From the 
data presented in Figure 5 it appears that the native HGG interfered 
with the response of these animals to challenge with aggHGG. This is 
contrary to what would be expected, namely, that the HGG would prime the 
animals for a secondary response upon contact with the aggregated anti­
gen. By virtue of their different physical conformations, native and 
aggregated HGG have determinant groups exposed which differ in quantity, 
specificity, and immunogenicity. It could be hypothesized that the ex­
perimental and tolerance control animals responded to determinant groups 
which were more prevalent on the native HGG molecules and which were 
only weakly immunogenic compared to the available determinant groups on 
the aggHGG. If this were so, at the time of challenge with aggHGG, the 
bulk of the available immunocompetent cells of these animals would have 
been previously committed to synthesizing antibody specific for the 
determinants of the native HGG molecule. The slight increase in the
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titer of these animals with time would be due to the presence, on the 
aggHGG, of a few of the determinant groups of the native HGG.
A 1.0 mg does of sHGG produced a significant degree of hypo- 
responsiveness in both lipid-treated and untreated, tolerance control 
BALB/c mice. This demonstrates, as noted above, the affect of the physi­
cal form of the antigen on its tolerogenicity. At this dose the sHGG 
was apparently just as influential as the lipid-mediated RES depression 
in inducing tolerance.
A similar response was observed to 10.0 mg doses of sHGG. The 
results of the 4 experiments employing this dose were compiled in Table 
18. Over 70 percent of the lipid-treated animals had titers of 2 or 
less logg units and were considered to be tolerant or hyporesponsive.
From 41 to 50 percent of the tolerance controls also had titers in this 
range. It appears, therefore, that both RES depression and the solu­
bility of the antigen influenced the response of these animals but that 
the latter factor exerted the stronger influence.
The ability of lipid-induced RES depression to alter the immune 
response to sHGG was most evident when a 5.0 mg dose was employed. In 
Table 17 it can be seen that at least 38 percent of the lipid-treated 
animals were hyporesponsive, whereas only 10 percent of the tolerance 
controls were depressed to the same extent (logg titers of 2 or less). 
Approximately half of the tolerance controls had titers ranging from 3 
to 5 logg units and the rest had titers of 6 or more, similar to those 
of the immunization control animals.
Perusal of Figures 3 through 17 reveals a high degree of vari­
ation between (1) individual animals within a given experimental or
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control group, (2) the 3 groups assayed at a specific time after immuni­
zation and, (3) the results of individual experiments employing identi­
cal dosages of sHGG. Some of this variation is undoubtedly the result 
of innate physiological differences commonly observed among individuals 
of a given strain or species. That individual animals vary considerably 
in their ability to respond to antigenic stimulation is evident from an 
examination of the hemagglutination titers within the various immuniza­
tion control groups employed in these experiments. For example, in 
Figure 3, the 4 week titers of the immunization control animals ranged 
from 4 - 1 0  logg units. Differences in the overall response of the 
various immunization control groups were also noted, i.e., at 2 weeks 
post-immunization the mean logg titers of these control groups ranged 
from 3.0 - 7.4, a difference of 4.4 log^ units. At 3, 4 and 5 weeks 
after immunization, these groups exhibited differences in mean titers 
of 4.8, 4.1 and 3.0 logg units, respectively. The mean titers of some 
immunization control groups increased gradually throughout the experi­
ment (Figure 6) while other such groups maintained a relatively constant 
mean titer during the course of the investigation (Figures 7, 8, 10, 12, 
15 and 17). The mean titers of still other immunization control groups 
were somewhat low (3.0 logg units) at 2 and 3 weeks post-immunization 
but increased by 2.5 - 3.0 logg units by the fourth week as exemplified 
in Figures 4,5, 9 and 14. A few groups which had relatively high mean 
titers 2 weeks post-challenge also manifested an increased mean titer by 
4 weeks (Figures 11 and 16) but this increase was generally not as great 
as in the case of those groups having low titers initially. Other than 
inherent individual animal variation, the major factors responsible for
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the variation in the immune response of the different immunization con­
trol groups were the preparation and administration of the antigen. 
Although the same preparation of aggHGG was employed in all experiments, 
it was emulsified in incomplete Freund's adjuvant just prior to injec­
tion and slight variations in the émulsification procedure from experi­
ment to experiment undoubtedly occurred. The antigen in adjuvant was 
injected subcutaneously. Undoubtedly some animals received slightly 
more or less than the specified dose of antigen. It is equally likely 
that some animals were inadvertently injected intraperitoneally rather 
than subcutaneously and in some cases, antigen may have entered by both 
routes. The effect of the route of antigen administration on antibody 
production has been reviewed by Hyde (1967).
The variation in the immune response of the immunization con­
trol animals was minimal compared to that observed in tolerance control 
and lipid-treated animals. In several experiments the titers of the 
tolerance control animals generally ranged between those of the experi­
mental and immunization control groups (Figures 11, 12 and 17), suggest­
ing that sHGG limited the response to a subsequent injection of aggHGG. 
However, in other cases, these control animals had low titers initially 
but by 4 or 5 weeks most were similar to the immunization control titers 
(Figure 3). Evidently, sHGG can delay the achievement of a normal immune 
response. In some instances a significant proportion of the tolerance 
control animals were tolerant or hyporesponsive (Figures 14 and 15).
Thus, no consistent pattern of response related to dose, or to any other 
factor, was evident for these control groups. Responsibility for the 
variation in these animals must, therefore, be attributed to sHGG
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preparations. The preparations used in these experiments were no doubt 
quite heterogeneous with regard to their relative proportions of aggre­
gated and monomeric components and, thus, would be expected to differ 
in tolerogenicity. The more these preparations are handled following 
ultracentrifugation the more opportunity there is for aggregation of 
the monomers. Such variables could not be identically controlled for 
each experiment. In addition to the factors already mentioned, the 
variation in the immune response of lipid-treated mice probably reflects 
the possibility that some mice did not receive a full dose of the lipid 
emulsion. Further, it was evident from the carbon clearance half-times 
of lipid-treated mice that these animals vary considerably in the extent 
and duration of the lipid-induced RES depression. It has been shown 
that, for tolerance to be induced in C57BL/6 mice, an interval of 4 days 
must intervene between administration of the tolerizing antigen and sub­
sequent challenge (Golub and Weigle, 1967b). It has not been established 
whether a similar interval is required for tolerance induction in BALB/c 
mice although it is reasonable to assume that such an interval would not 
vary greatly among different mouse strains. It may be that the RES of 
a significant proportion of the lipid-treated mice was not sufficiently 
depressed throughout this 4 day period to allow the establishment of a 
completely tolerant state. It is also possible that BALB/c mice require 
a longer interval for tolerance induction. If so, this may be one rea­
son why this strain is so difficult to render tolerant.
The results of this investigation, while not as definitive as 
had been hoped, are far from equivocal. It has been amply demonstrated 
that a significant proportion of mice treated with the RES depressants,
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ethyl stearate and methyl palmitate, are severely limited in their 
ability to respond to an antigenic stimulus. The fact that this was 
demonstrated in BALB/c mice, a strain well known for its resistance to 
tolerance induction, is particularly significant. Certainly these find­
ings support the hypothesis that at least one mechanism of tolerance in­
duction involves the absence of appropriate antigen-processing by cells 
of the RES.
When the sera of the BALB/c mice employed in the tolerance in­
duction experiments were titrated using BSA as a diluent, all animals 
exhibited a marked increase in hemagglutination titer. This high BSA 
titer was evident at 2 weeks post-immunization and remained remarkably 
constant throughout the course of these experiments (Figure 18). This 
BSA-DAB was not induced as a result of either lipid treatment or the 
administration of sHGG since both the tolerance controls, which did not 
receive lipid, and the immunization controls, which did not receive 
sHGG, had similar hemagglutination titers in the BSA diluent. It is 
noteworthy that C57BL/6 mice did not have significantly increased BSA 
titers. In fact, the PBGS and BSA titers of these animals were nearly 
identical.
BSA-detectable antibody (BSA-DAB) was not detected in the serum 
of normal BALB/c mice. It appears to have reached near maximum levels 
by 2 weeks after immunization in all groups of animals. The relative 
increase in hemagglutinin activity in the presence of BSA is obviously 
greatest in mice which have the most profound immune depression as de­
tected by titration in PBSG. In fact, animals which would be considered 
completely tolerant by the PBSG titration criterion had BSA-DAB levels
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similar to those seen in immunization control mice. Hence, absolute 
tolerance was never achieved in this study. Similar observations have 
been documented in which animals deemed tolerant by one assay were found 
to have specific antibody titers when evaluated by a different procedure 
(Linscott and Weigle, 1965; Weigle and Fudenberg, 1966; Henney and 
Ishizaka, 1967). Another point worth mentioning is the fact that the 
passive hemagglutination assay, which was used in the present study, is 
a more sensitive detector of IgM than IgG antibody (Borel, e^ al., 1968). 
There is, however, no evidence to suggest that employing BSA as a diluent 
should further enhance its sensitivity for IgM or any other class of 
complete antibody. One would not expect IgM to be the predominating 
antibody throughout the experiments reported here. However, it is known 
that considerable variation exists among mouse strains with regard to 
the relative concentration and duration of immunoglobulin classes com­
prising an antibody response to antigenic stimulation. Warner, et al. 
(1968) immunized 5 strains of mice with dinitrophenylated hemocyanin.
Two strains synthesized relatively less IgG than the others but had sig­
nificant amounts of 2-mercaptoethanol-sensitive antibody present as long 
as 80 days post-immunization. The difference in PBSG and BSA hemaggluti­
nation titers of an individual animal is reminiscent of an immunological 
phenomenon known as immune deviation or split tolerance. Immune devia­
tion refers to the antigen-induced abolishment or diminution of certain 
types of immune responses, while other types are unaffected. The classic 
example of immune deviation is the suppression of delayed hypersensi­
tivity without affecting the humoral antibody response. Asherson and 
Stone (1965) demonstrated suppression of delayed hypersensitivity to
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BGG or HSA in guinea pigs by treating them with alum-precipitated BGG 
or HSA prior to immunization with the respective antigen in complete 
Freund's adjuvant. Total antibody production was not altered. In some 
instances depression of Vz'^'^tibody synthesis was observed concomitantly 
with suppression of delayed hypersensitivity, while production of Yi~ 
antibody remained unchanged. In fact, by manipulating the conditions 
required for the induction of immune deviation, such as the dosage and 
time of administration of the alum-precipitated antigen, delayed hyper­
sensitivity, delayed hypersensitivity and y^-antibody production or de­
layed hypersensitivity, and y^-antibody production could be suppressed 
(Asherson, 1967; Dvorak and Flax, 1966; Dvorak, et , 1965). Immune 
deviation has also been produced by administering the antigen in incom­
plete Freund's adjuvant prior to sensitization (Dvorak, e^ ̂ . , 1966; 
Loewi, e£ ̂ . , 1966) or with soluble antigen (Dvorak and Flax, 1966). 
Immune deviation is probably a fairly common occurrence. It has been 
observed frequently in guinea pigs (Asherson and Stone, 1965; Dvorak,
£t ̂ . , 1965, 1966) and in mice (Crowle and Hu, 1966) employing numerous 
antigens including HSA, BGG, BSA, ribonuclease (Dvorak, et al., 1965, 
1966), blood-group substance (Loewi, £t ^ . , 1966) and egg albumin 
(Loewi, et al., 1966; Crowle and Hu, 1966). Other observations which 
might be classed as examples of immune deviation, had the appropriate 
humoral antibody quantitations been made, include suppression of delayed 
hypersensitivity in guinea pigs to tuberculin, which normally follows 
immunization with BCG, by the prior injection of purified protein deriv­
ative (PPD) (Boyden, 1957) and the prolonged survival of skin homografts 
in mice previously immunized with lyophilized spleen tissue, emulsified
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in incomplete Freund's adjuvant, from donor mice (Chutna, 1968). More 
germane to the present study are examples of possible split tolerance 
which pertain only to variations in humoral antibody formation. Borel, 
et al. (1968) noted that IgM antibody production was inhibited more 
readily and to a greater extent than was IgG antibody following the ad­
ministration of deaggregated (ultracentrifuged) BGG to rabbits. Chickens 
injected with very small amounts of HSA (500 y) synthesized only IgM 
antibody, whereas massive quantities of HSA (2500 mg) induced a form of 
split tolerance in that the only serum antibody detectable was IgG. 
Subsequent challenge with 10 mg of HSA, which normally stimulates IgM 
production, failed to do so in this case (Cerny and Ivanyi, 1967).
Characterization of the BSA-DAB revealed it to be heat labile 
at 56c for 30 minutes. Titration of heat-inactivated sera using fresh, 
normal mouse serum as a diluent failed to reconstitute activity. There­
fore, the decreased BSA titers of heated sera were not due to inactiva­
tion of complement. Further, the BSA-DAB titers ranged from 9 to 10.5 
logg units and it is doubtful that a 1:1,024 dilution of serum contains 
a sufficient amount of complement to effectively participate in an anti- 
gen-antibody reaction. Further observations suggested that the BSA-DAB 
in the serum of lipid-treated and tolerance control animals may be sensi­
tive to multiple freeze-thawings and prolonged storage in a frozen state.
The specificity of the antibodies produced in the BALB/c mice 
was investigated by means of absorption and in vitro inhibition assays. 
Both PBSG and BSA titers were abolished by prior absorption of mouse 
sera with a 2 mg/ml concentration of HGG. Further, titration of mouse 
sera in the presence of excess HGG also abolished or drastically decreased
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both the PBSG and BSA titers.
The BSA-DAB differed from the antibody detected by titration in 
the PBSG diluent in that the former cross-reacted with MGG, whereas the 
latter did not. In fact, higher hemagglutination titers were obtained 
when SRBC were sensitized with MGG than with HGG. This would be expected 
if less MGG was conjugated to SRBC than was HGG which would result in a 
more sensitive assay. On the other hand, BSA-DAB may be an antibody 
which cross reacts with a determinant group present on HGG and Swiss- 
Webster MGG (the commercially obtained MGG was prepared from Swiss- 
Webster mice), but not on BALB/c gamma globulin, and is more specific 
for Swiss-Webster MGG than for HGG.
Several similarities were noted in the characteristics of BSA- 
DAB and rheumatoid factor (RF). Both react with isoantigens and hetero­
antigens and both react with IgG (RF reacts with IgG exclusively). 
Titration in a protein diluent potentiates the titer of both materials. 
When titrating RF by the SRBC agglutination test, substituting sheep 
serum for saline as a diluent increases the RF titer 4 to 500-fold 
(Epstein, 1957). BSA-DAB and RF appear to differ in their heat stability. 
Rheumatoid factor is stable when heated up to 78C for 30 minutes (Ziff, 
1957), whereas BSA-DAB was inactivated at 56C for 30 minutes. However, 
preliminary investigations have shown that heated, normal BALB/c serum, 
present in a 1:10 dilution in BSA, inhibits BSA-DAB produced in BALB/c 
mice (Hyde and Rice, 1970). They suggest that the apparent heat lability 
of BSA-DAB may be an artifact resulting from the "sponging up" of anti­
body by gamma globulin which was denatured or aggregated during serum 
inactivation. If this is true, it further supports the thesis that
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BSA-DAB and RF are the same since RF is currently thought to react pri­
marily with gamma globulin determinant groups which are not exposed 
unless the molecule is immunologically denatured, as in formation of an 
antigen-antibody complex (Christian, 1967). It is quite probable that 
some HGG is denatured in the process of becoming coupled to SRBC with 
BDB. Perhaps, then, BSA-DAB reacts with HGG determinant groups exposed 
during this procedure. One problem with this hypothesis is the fact 
that reaction between RF and sensitized particles is not inhibited by 
native IgG, whereas, as demonstrated in this study, BSA-DAB is inhibited. 




Ethyl stearate and methyl palmitate, administered separately or 
in combination, were equally effective as RES depressants in mice, as 
determined by the intravascular clearance of colloidal carbon. Maximum 
depression of RES function occurred 24 hours after lipid administration. 
Normal function was regained in 4 to 10 days. A combination of these 
lipids produced a decidedly more profound impairment of RES activity in 
C57BL/6 mice than in BALB/c mice. However, normal C57BL/6 mice cleared 
carbon from the circulation more rapidly than did mice of the BALB/c 
strain. Considerable variation existed in the susceptibility of indi­
vidual animals to lipid-induced RES depression. Animals also varied in 
normal RES activity as evaluated by the carbon clearance technique.
Lipid-induced RES depression enhanced the induction of a toler­
ant or hyporesponsive state to sHGG in a significant proportion of 
BALB/c mice. This was most evident when a 5.0 mg dose of sHGG was em­
ployed. Soluble HGG, alone, rendered some normal animals hyporesponsive 
or tolerant and appeared to delay or limit the normal immune response of 
many animals to a subsequent injection of aggHGG. These findings sup­
port the hypothesis that tolerance may be induced to an antigen when it 
has not been appropriately processed by macrophages.
Titration of BALB/c sera, but not C57BL/6 sera, in the presence
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of BSA resulted in markedly increased hemagglutination titers in all 
animals. These titers had reached maximum levels by 2 weeks post-immuni­
zation and remained relatively constant throughout the experiment. The 
similarity between these observations and those seen in immune deviation 
were noted.
Characterization of BSA-DAB revealed it to be heat-labile. 
Inactivation of complement was not thought to be responsible for the 
heat-lability. The BSA-DAB cross reacted with HGG and MGG from the 
Swiss-Webster strain. Some evidence was obtained which suggested that 
BSA-DAB may lose activity when subjected to multiple freeze-thawing or 
prolonged storage in a frozen state. Similarities in the characteris­
tics of BSA-DAB and rheumatoid factor exist and it seems possible that 
these materials might be a single entity.
BIBLIOGRAPHY
Allison, A. C., Harington, J. S. and Birbeck, M. 1966. An examination 
of the cytotoxic effects of silica on macrophages. J. Exp.
Med., m :  141-153.
Argyris, B. F. 1968. Role of macrophages in immunological maturation.
J. Exp. Med., 459-467.
Argyris, B. F. and Askonas, B. A. 1968. Mouse peritoneal cells: their
ability to elicit or produce antibody after exposure to antigen. 
Immunol., 1̂ : 379-392.
Argyris, B. F. and Plotkin, D. H. 1969. Effect of antimacrophage serum 
on antibody production and phagocytosis in mice. J. Immunol., 
103: 372-373.
Arteta, J. L. 1956. The microglia and the reticuloendothelial system. 
Research on the histiocytic significance of the microglia.
RES Bull., 2: 9-13.
Aschoff, L. 1924. Lectures on Pathology. Paul B. Hoeber, Inc., New 
York.
Asherson, G. L. 1967. Antigen-mediated depression of delayed hyper­
sensitivity. Brit. Med. Bull., 23: 24-29.
Asherson, G. L. and Stone, S. H. 1965. Selective and specific inhibi­
tion of 24 hour skin reactions in the guinea pig. I. Immune 
deviation: description of the phenomenon and the effect of 
splenectomy. Immunol., 205-217.
Askonas, B. A. and Rhodes, J. M. 1965. Immunogenicity of antigen- 
containing ribonucleic acid preparations from macrophages.
Nature 205: 470-474.
Baillif, R. N. 1956. Delineation of the RES. RES Bull., 3-4.
Balner, H., Old, L. J. and Clarke, D. A. 1962. Accelerated rejection 
of male skin isografts by female C57BL mice infected with 




Benacerraf, B., Biozzi, G., Halpern, B. N. and Stiffel, C. 1957. Physi­
ology of phagocytosis of particles by the RES, in Physiopatho- 
logy of the Reticuloendothelial System, Edited by B. N. Halpern,
B. Benacerraf and J. F. Delafresnaye, p. 52-77, Charles C.
Thomas, Springfield.
Benacerraf, B., Halpern, B. N., Biozzi, G. and Benos, S. A. 1954. Quan­
titative study of the granulopectic activity of the reticulo­
endothelial system. III. The effect of cortisone and nitrogen 
mustard on the regenerative capacity of the RES after saturation 
with carbon. Brit. J. Exp. Path., 97-106.
Berglund, K. 1956. Studies on factors which condition the effect of
cortisone on antibody production. I. The significance of time 
of hormone administration in primary hemolysin response. Acta 
Pathol. Microbiol, Scand., 311-328.
Biozzi, G., Benacerraf, B., and Halpern, B. N. 1953. Quantitative
study of the granulopectic activity of the reticulo-endothelial 
system. II. A study of the kinetics of the granulopectic 
activity of the RES in relation to the dose of carbon injected. 
Relationship between the weight of the organs and their acti­
vity. Brit. J. Exp. Path., 34 441-457.
Biro, C. E. and Garcia, G. 1965. The antigenicity of aggregated and 
aggregate-free human gamma-globulin for rabbits. Immunol., 
411-419.
Blickens, D. A. and DiLuzio, N. R. 1965. Metabolism of methyl palmitate, 
a phagocytic and immunologic depressant, and its influence on 
tissue lipids. RES, J. Reticuloendothelial Soc., 60-74.
Borel, Y., Franklin, E. C. and Miescher, P. A. 1968. The effect of
unaggregated bovine y-globulin on yM and yG antibody formation. 
Immunol., "IM 899-909.
Box, G. E. P. 1954. Some theorems on quadratic forms applied in the 
study of analysis of variance problems. Ann. Math. Statist.,
25; 290-302 and 484-498. Cited ̂  Statistical Principles 
in Experimental Design, Winer, B. J. (McGraw-Hill, New York,
1962).
Boyden, S. V. 1957. The effect of previous injections of tuberculo-
protein on the development of tuberculin sensitivity following 
BCG vaccination in guinea pigs. Brit. J. Exp. Path., 38:
611-617.
Buchanan, K. D. and MacGregor, R. F. S. 1964. Prolongation of the 
survival of human red cells in mice by chemical splenectomy.
Brit. J. Exp. Path., 45: 248-251.
128
derny, J. and Ivanyi, J. 1967. Variation in tolerance dose require­
ments as related to heterogeneity of the immune response.
Nature m :  1017-1018.
Christian, C. L. 1967. Rheumatoid factors. A. Nature and signifi­
cance of rheumatoid factors, in Laboratory Diagnostic Procedures 
in the Rheumatic Diseases, Edited by A. S. Cohen, p. 84-95, 
Little, Brown, and Co., Boston.
Chutna, J. 1968. Enhancement of skin homografts and dissociation of 
immune responses in mice immunized with lyophilized tissues 
in Freund’s adjuvant. Nature 217 : 175-177.
Claman, H. N. 1963. Tolerance to a protein antigen in adult mice and 
the effect of nonspecific factors. J. Immunol., 91̂: 833-839.
Cline, M. J. and Swett, V. C. 1968. The interaction of human monocytes
and lymphocytes. J. Exp. Med., 128: 1309-1325.
Cohen, E. P. 1967. Conversion of non-immune cells into antibody-form­
ing cells by RNA. Nature 213; 462-465.
Cohen, E. P. 1968. Analysis by molecular hybridization of RNA from
immunocompetent cells exposed to antigen. RES, J. Reticulo­
endothelial Soc., abstract number 29, Fifth Annual National 
Meeting.
Cohen, E. P., Newcomb, R. W. and Crosby, L. K. 1965. Conversion of non-
immune spleen cells to antibody-forming cells by RNA: Strain
specificity of the response. J. Immunol., 9̂ : 583-590.
Cohen, E. P. and Parks, J. J. 1964. Antibody production by nonimmune
spleen cells incubated with RNA from immunized mice. Science 
144 : 1012-1013.
Conning, D. M. and Heppleston, A. G. 1966. Reticuloendothelial acti­
vity and local particle disposal. A comparison of the influence 
of modifying agents. Brit. J. Exp. Path., 388-400.
Cooper, G. N. and Stuart, A. E. 1961. Sensitivity of mice to bacterial
lipopolysaccharide following alteration of activity of the 
reticulo-endothelial system. Nature 191: 294-295.
Cooper, G. N. and Stuart, A. E. 1962. Susceptibility of mice to pneumo­
coccal infection after modification of the reticulo-endothelial 
system with simple lipids. J. Path. Bact., 83: 227-243.
Crowle, A. J. and Hu, C. C. 1966. Split tolerance affecting delayed 
hypersensitivity and induced in mice by pre-immunization with 
protein antigens in solution. Clin. Exp. Immunol., 1: 323-335.
129
Cruchaud, A. 1968. The effect of reticuloendothelial blockade on anti­
body formation and immunologic tolerance. Lab. Invest., 19 : 
15-24.
Cutler, J. L. 1960. The enhancement of hemolysin production in the 
rat by zymosan. J. Immunol., 416-419.
Despont, J. P. and Cruchaud, A. 1969. In vivo and in vitro effects of
anti-macrophage serum. Nature 223: 838-839.
Dietrich, F. M. and Weigle, W. 0. 1964. Immunologic unresponsiveness
to heterologous serum proteins induced in adult mice and trans­
fer of the unresponsive state. J. Immunol., 167-172.
Diller, I. C., Fisher, M. E. and Gable, D. 1964. Effect of glucan on
mouse sarcoma 37. Proc. Soc. Exp. Biol. Med., 117: 107-110.
DiLuzio, N. R. 1969. Personal communication.
DiLuzio, N. R. and Blickens, D. A. 1966. Influence of intravenously 
administered lipids on reticuloendothelial function. RES, J. 
Reticuloendothelial Soc., 2= 250-270.
DiLuzio, N. R. and Riggi, S. J. 1964. The development of a lipid emul­
sion for the measurement of reticuloendothelial function. RES, 
J. Reticuloendothelial Soc., 2= 136-149.
DiLuzio, N. R. and Wooles, W. R. 1964. Depression of phagocytic acti­
vity and immune response by methyl palmitate. Amer. J. Physiol. 
206; 939-943.
Dresser, D. W. 1961. Effectiveness of lipid and lipidophilic sub­
stances as adjuvants. Nature 191: 1169-1171.
Dresser, D. W. 1962. Specific inhibition of antibody production. II.
Paralysis induced in adult mice by small quantities of protein 
antigen. Immunol., _5* 378-388.
Dresser, D. W. 1963. Specific inhibition of antibody production. III.
Apparent changes in the half-life of bovine gamma globulin in
paralysed mice. Immunol., i6 : 345-355.
Dvorak, H. F., Billote, J. B., McCarthy, J. S. and Flax, M. H. 1965.
Immunologic unresponsiveness in the adult guinea pig. I. Sup­
pression of delayed hypersensitivity and antibody formation to 
protein antigens. J. Immunol., ^4: 966-975.
Dvorak, H. F., Billote, J. B., McCarthy, J. S. and Flax, M. H. 1966.
Immunologic unresponsiveness in the adult guinea pig. III.
Variation of the antigen and vehicle of suppression. Induction
of unresponsiveness in the adult rat. J. Immunol., 97: 106-111.
130
Dvorak, H. F. and Flax, M. H. 1966. Immunologie unresponsiveness in 
the adult guinea pig. II. The kinetics of unresponsiveness.
J. Immunol., £6_: 546-553.
Epstein, W. 1957. Serological Reactions of Rheumatoid Arthritis,
Edited by R. W. Lamong-Havers, p. 17, Issued by The Arthritis 
and Rheumatism Foundation.
Feldman, M. and Gallily, R. 1967. Cell interactions in the induction 
of antibody formation. Cold Springs Harbor Symp. Quant. Biol., 
32: 415-421.
Fenn, W. 0. 1921a. The phagocytosis of solid particles. II. Carbon.
J. Gen. Physiol., _3: 465-482.
Fenn, W. 0. 1921b. The phagocytosis of solid particles. III. Carbon
and quartz. J. Gen. Physiol., 575-593.
Fishman, M. 1959. Antibody formation in tissue culture. Nature 183:
1200-1201.
Fishman, M. 1961. Antibody formation in vitro. J. Exp. Med., 114:
837-856.
Fishman, M. and Adler, F. L. 1963. Antibody formation initiated in
vitro. II. Antibody synthesis in X-irradiated recipients of 
diffusion chambers containing nucleic acid derived from macro­
phages incubated with antigen. J. Exp. Med., 117: 595-602.
Fishman, M. and Adler, F. L. 1967. The role of macrophage-RNA in the
immune response. Cold Springs Harbor Symp. Quant. Biol., 32: 
343-348.
Fishman, M., Hammerstrom, R. A. and Bond, V. P. 1963. In vitro trans­
fer of macrophage RNA to lymph node cells. Nature 198: 549-551.
Fong, J., Chin, D. and Elberg, S. S. 1963. Studies of tubercle
bacillus-histiocyte relationships. VI. Induction of cellular 
resistance by ribosomes and ribosomal RNA. J. Exp. Med., 118: 
371-386.
Forbes, I. J. 1969. Analysis in vitro of tolerance. Immunol., 16: 
699-706.
Frei, P. C., Benacerraf, B. and Thorbecke, G. J. 1965. Phagocytosis
of the antigen, a crucial step in the induction of the primary 
response. Proc. Nat. Acad. Sci. USA, 20-23.
Frei, P. C., Cruchaud, S., Arnaudo, L. and Vannotti, A. 1968. Immuno­
logic tolerance induced in the adult rabbit with modified BSA.
J. Immunol., 101: 605-610.
131
Friedman, H. P., Stavitsky, A. B. and Solomon, J. M. 1965. Induction 
in vitro of antibodies to phage T2: antigens in the RNA ex­
tract employed. Science 149 : 1106-1107.
Frisch, A. W. and Wilson, B. J. 1969. Cell transfer studies in immuno-
suppressed mice: the role of the macrophage. Proc. Soc. Exp.
Biol. Med., m :  42-45.
Gamble, C. N. 1966. The role of soluble aggregates in the primary
immune response of mice to human gamma globulin. Int. Arch. 
Allergy _30.: 446-455.
35Garvey, J. S. and Campbell, D, H. 1957. The retention of S -labelled 
bovine serum albumin in normal and immunized liver tissue. J. 
Exp. Med., 1^: 361-372.
Gershon, H. and Felman, M. 1968. Studies on the immune reconstitution
of sublethally irradiated mice by peritoneal macrophages.
Immunol., 1̂ : 827-835.
Golub, E. S. and Weigle, W. 0. 1967a. Studies on the induction of im­
munologic unresponsiveness. I. Effects of endotoxin and phyto­
hemagglutinin. J. Immunol., £8: 1241-1247.
Golub, E. S. and Weigle, W. 0. 1967b. Studies on the induction of
immunologic unresponsiveness. II. Kinetics. J. Immunol., 99:
624-628.
Golub, E. S. and Weigle, W. 0. 1969. Studies on the induction of
immunologic unresponsiveness. III. Antigen form and mouse
strain variation. J. Immunol., 102: 389-396.
Gordon, J. 1968. Role of monocytes in the mixed leukocyte culture re­
action. Proc. Soc. Exp. Biol. Med., 127: 30-33.
Halpern, B. N., Benacerraf, B. and Biozzi, G. 1953. Quantitative study
of the granulopectic activity of the reticulo-endothelial system.
I. The effect of the ingredients present in India ink and of 
substances affecting blood clotting in vivo on the fate of car­
bon particles administered intravenously in rats, mice and 
rabbits. Brit. J. Exp. Path., 3£: 426-440.
Halpern, B. N., Biozzi, G., Mené, G., and Benacerraf, B. 1951. Étude 
quantitative de l'activité granulopexique du système reticulo­
endothelial par 1'injection intravenineuse dencre de chine chez 
les diverses espaces animales. Ann. Inst. Pasteur 8£: 582-604.
Halpern, B. N., Biozzi, G., Stiffel, C. and Mouton, D. 1958. Corréla­
tion entre l'activité phagocytaire du système reticulo-endo- 
thélial et la production d'anticorps antibactériens. C. R.
Soc. Biol., 152: 758-761.
132
Hanan, R. and Oyama, J. 1954. Inhibition of antibody formation in 
mature rabbits by contact with the antigen at an early age.
J. Immunol., 73: 49-53.
Heller, J. H. 1955. Cortisone and phagocytosis. Endocrinol., 56;
80-85.
Henney, C. S. and Ishizaka, K. 1967. Immunological unresponsiveness 
to specific antigenic determinants in human .yG globulin.
Proc. Soc. Exp. Biol. Med., 125: 335-341.
Hersh, E. M. and Harris, J. E. 1968. Macrophage-lymphocyte interaction 
in the antigen-induced blastogénie response of human peripheral 
blood leucocytes. J. Immunol., 100: 1184-1194.
Hirsch, M. S., Gary, G. W., Jr., and Murphy, F. A. 1969. In vitro and 
in vivo properties of antimacrophage sera. J. Immunol., 102: 
656-661.
Howard, R. J., Mergenhagen, S. E., Notkins, A. L. and Dougherty, S. F.
1969. Inhibition of cellular immunity and enhancement of hu­
moral antibody formation in mice infected with lactic dehydro­
genase virus. Transplant. Proc., 586-588.
Hyde, R. M. 1967. Antiserum production in experimental animals.
Advances Appl. Microbiol., 9_: 39-67.
Hyde, R. M., Garb, S. and Bennett, A. J. 1967. Demonstration by immuno- 
electrophoresis of antigen in human myelogenous leukemia. J. 
Nat. Cancer Inst. 909-919.
Hyde, R. M. and Rice, J. E. 1970. Unpublished data.
Jennings, J. F. and Oates, C. M. 1967. Studies on the nonspecific
depression of the immune response. J. Exp. Med., 126: 557-564.
Kalckar, H. M. 1947. Differential spectrophotometry of purine compounds 
by means of specific enzymes. III. Studies of the enzymes of 
purine metabolism. J. Biol. Chem., 167 ; 461-475.
Karthigasu, K., Reade, P. C. and Jenkin, C. R. 1965. The functional 
development of the reticulo-endothelial system. III. The 
bactericidal capacity of fixed macrophages of foetal and 
neonatal chicks and rats. Immunol., 9_: 67-73.
Kessel, R. W. I., Monaco, L. and Marchisio, M. A. 1963. The specificity
of the cytotoxic action of silica - a study in vitro. Brit.
J. Exp. Path., 351-364.
Kong, Y. M. and Cheng, J. K. 1970. Immunologic tolerance to a protein
antigen in adult mice: challenge with an aggregated fraction.
Fed. Proc., 29: abstract number 352.
133
Kramer, T. R. 1970. Personal communication.
Linscott, W. D. and Weigle, W. 0. 1965. Induction of tolerance to
bovine serum albumin by means of whole-body X-radiation. J. 
Immunol., 430-436.
Loewi, G., Holborow, E. J. and Temple, A. 1966. Inhibition of delayed 
hypersensitivity by pre-immunization without complete adjuvant. 
Immunol., 339-347.
Loewi, G., Temple, A., Nind, A. P. and Axelrad, M. 1969. A study of 
the effects of anti-macrophage sera. Immunol., 99-106.
Mannick, J. A. and Egdahl, R. H. 1962. Ribonucleic acid in "transfor­
mation" of lymphoid cells. Science 137: 976-977.
Martin, W. J. 1966. The cellular basis of immunological tolerance in 
newborn animals. Aust. J. Exp. Biol. Med. Sci., 605-608.
Medawar, P. B. 1963. Concluding remarks in. Acquired or natural toler­
ance toward defined protein antigens. Edited by E. S. Bussard,
C. N. R. S. Symposium, Academic Press, New York and London.
Melnick, H. D. and Friedman, H. 1969. The immunosuppressive effect 
of RES "blockade" with ethyl stearate emulsion on cellular 
formation of antibody to sheep erythrocytes. Proc. Soc. Exp. 
Biol. Med., 1^: 423-427.
Metchnikoff, E. 1907. Immunity in Infective Diseases. Binnie, F. G. 
(trans.). University Press, Cambridge.
Mergenhagen, S. E., Notkins, A. L. and Dougherty, S. F. 1967. Adju- 
vanticity of lactic dehydrogenase virus: influence of virus 
infection on the establishment of immunologic tolerance to a 
protein antigen in adult mice. J. Immunol., 576-581.
Mitchell, G. F. and Miller, J. F. A. P. 1968. Immunological activity 
of thymus and thoracic-duct lymphocytes. Proc. Nat. Acad. Sci. 
USA, 59: 296-303.
Mitchell, J. and Nossal, G. J. V. 1966. Mechanism of induction of
immunological tolerance. I. Localization of tolerance-induc­
ing antigen. Aust. J. Exp. Biol. Med. Sci., 211-224.
Mitchison, N. A. 1969. The immunogenic capacity of antigen taken up 
by peritoneal exudate cells. Immunol., 1̂ : 1-14.
Morrow, S. H. and DiLuzio, N. R. 1965. The fate of foreign red cells 
in mice with altered reticuloendothelial function. Proc. Soc. 
Exp. Biol. Med., 119: 647-652.
134
Hosier, D. E. 1967. A requirement for two cell types for antibody 
formation in vitro. Science 158: 1573-1575.
Mountain, I. M. 1955. Antibody production by spleen in vitro. I.
Influence of cortisone and other chemicals. J. Immunol., 74; 
270-277.
Neukomm, S., Lerch, P. and Jallut, 0. 1957. Physicochemical factors
governing the phagocytic function of the RES, in Physiopathology 
of the Reticulo-endothelial System, Edited by B. N. Halpern,
B. Benacerraf and J. F. Delafresnaye, p. 115-127, Charles C. 
Thomas, Springfield.
Nicol. T. and Bilbey, D. L. J. 1958. Substances depressing the phago­
cytic activity of the reticulo-endothelial system. Nature 182 : 
606.
Ohbuchi, S. 1968. Suppression of antibody formation by the RES-block- 
ade. III. Effects of the RES-blockade with methyl palmitate. 
Acta. Med. Okayama 2̂ : 137-146.
Old, L. J., Clarke, D. A., Benacerraf, B. and Goldsmith, M. 1960. The 
reticuloendothelial system and the neoplastic process. Ann.
N. Y. Acad. Sci., 264-280.
Oppenheim, J. J., Leventhal, B. G. and Hersh, E. M. 1968. The trans­
formation of column-purified lymphocytes with nonspecific and 
specific antigenic stimuli. J. Immunol., 101: 262-270.
Panijel, J. and Cayeux, P. 1968. Immunosuppressive effects of macro­
phage antiserum. Immunol., 1̂ : 769-780.
Pearsall, N. N. and Weiser, R. S. 1968. The macrophage in allograft
immunity. I. Effects of silica as a specific macrophage toxin. 
RES, J. Reticuloendothelial Soc., 107-120.
Pierce, C. W. 1969. Immune responses in vitro. I. Cellular require­
ments for the immune response by nonprimed and primed spleen 
cells in vitro. J. Exp. Med., 130: 345-364.
Pierce, C. W. and Benacerraf, B. 1969. Immune response in vitro: 
independence of "activated" lymphoid cells. Science 166: 
1002-1003.
Pinchuck, P., Fishman, M., Adler, F. L. and Maurer, P. H. 1968. Anti­
body formation : initiation in "nonresponder." mice by macro­
phage synthetic polypeptide RNA. Science 160: 194-195.
Pinckard, R. N., Weir, D. M. and McBride, W. H. 1967. Factors influenc­
ing the immune response. I. Effects of the physical state of 
the antigen and of lymphoreticular cell proliferation on the re­
sponse to intravenous injection of bovine serum albumin in 
rabbits. Clin. Exp. Immunol., 2: 331-341.
135
Pinckard, R. N., Weir, D. M. and McBride, W. H. 1968. Factors in­
fluencing the immune response. III. The blocking effect of 
Corynebacterium parvum upon the induction of acquired immuno­
logical unresponsiveness to bovine serum albumin in the adult 
rabbit. Clin. Exp. Immunol., 413-421.
Pribnow, J. F. and Silverman, M. S. 1967. Studies on the radiosensi­
tive phase of the primary antibody response in rabbits. I.
The role of the macrophage. J. Immunol., 225-229.
Prosnitz, L, Kawasaki, S., Cohen, G. S., Dineen, J. L., Perille, P. E.
and Finch, S. C. 1969. Ethyl palmltate-induced splenic de­
struction. RES, J. Reticuloendothelial Soc., 6_: 487-497.
Reade, P. C. and Jenkin, C. R. 1965. The functional development of the 
reticulo-endothelial system. I. The uptake of intravenously 
injected particles by foetal rats. Immunol., 53-60.
Riggi, S. J. and DiLuzio, N. R. 1961. Identification of a reticulo­
endothelial stimulating agent in zymosan. Amer. J. Physiol., 
200: 297-300.
Roelants, G. E. and Goodman, J. W. 1968. Immunochemical studies on the 
poly-Y -D- glutamyl capsule of Bacillus anthracis. IV. The 
association with peritoneal exudate cell ribonucleic acid of 
the polypeptide in immunogenic and nonimmunogenic forms.
Biochem., 7̂: 1432-1440.
Roelants, G. E. and Goodman, J. W. 1969. The chemical nature of macro­
phage RNA-antigen complexes and their, relevance to immune induc­
tion. J. Exp. Med., 130: 557-574.
Roseman, J. 1969. X-ray resistant cell required for the induction of 
in vitro antibody formation. Science 165: 1125-1127.
Roser, B. 1965. The distribution of intravenously injected peritoneal
macrophages in the mouse. Aust. J. Biol. Med. Sci., 43:
553-562.
Roser, B. 1968. The distribution of intravenously injected Kupffer
cells in the mouse. RES, J. Reticuloendothelial Soc.,
455-471.
Ryder, J. W. and Schwartz, R. S. 1969. Immunosuppression by antibody: 
localization of site of action. J. Immunol., 103; 970-978.
Saba, T. M. and DiLuzio, N. R. 1968. Evaluation of humoral and cellular 
mechanisms of methyl palmitate induced reticuloendothelial 
depression. Life Sciences 7: 337-347.
136
Sabet, T. and Friedman, H. 1969. Immunologic "amnesia" of antibody- 
forming cells after RES blockade. Proc. Soc. Exp. Biol. Med., 
131; 1317-1322.
Sabet, T., Newlin, C. and Friedman, H. 1968. The effect of RES block­
ade on cellular antibody formation to sheep .erythrocytes.
Proc. Soc. Exp. Biol. Med., 128: 274-278.
Sabet, T., Newlin, C. and Friedman, H. 1969. Effects of RES "blockade" 
on antibody-formation. I. Suppressed cellular and humoral 
haemolysin responses in mice injected with carbon particles. 
Immunol., 1̂ : 433-446.
Shivas, A. A. and Fraser, G. P. 1959. Lymphoid .necrosis induced by
lipid emulsions. Nature 184: 1813.
Smith, R. T. 1961. Immunological tolerance of nonliving antigens. 
Advances Immunol. , _1: 67-129.
Stavitsky, A. B. and Arquilla, E. R. 1955. Micromethods for the study 
of proteins and antibodies. III. Procedure and applications 
of hemagglutination and hemagglutination-inhibition reactions 
with bis-diazotized benzidine and protein-conjugated red blood 
cells. J. Immunol., 306-312.
Stuart, A. E. 1960. Chemical splenectomy. Lancet 2̂: 896-897.
Stuart, A. E. 1962. Effect of cholesterol oleate on the phagocytic
function of the reticulo-endothelial system. Nature 196 :
78-79.
Stuart, A. E., Biozzi, G., Stiffel, C., Halpern, B. N. and Mouton, D.
1960. The stimulation and depression of reticulo-endothelial 
phagocytic function by simple lipids. Brit. J. Exp. Path., 
599-604.
Stuart, A. E. and Cooper, G. N. 1962. Susceptibility of mice to bac­
terial endotoxin after modification-of.reticulo-endothelial 
function by simple lipids. J. Path. Bact., 245-254.
Stuart, A. E. and Davidson, A. E. 1963. The effect of intravenous
cholesterol oleate on the function of the reticuloendothelial 
system. Brit. J. Exp. P a t h . , 24-30.
Sulitzeanu, D. 1968. Affinity of antigen for white cells and its rela­
tion to the induction of antibody formation. Bacteriol. Rev., 
404-424.
Taber, R. and Irwin, S. 1969. Anesthesia in the mouse. Fed. Proc.,
28: 1528-1532.
137
Unanue, E. R. 1968. Properties and some uses of anti-macrophage anti­
bodies. Nature 218 ; 36-38.
Unanue, E. R. and Askonas, B. A. 1968. The immune response of mice to
antigen in macrophages. Immunol., : 287-296.
Unanue, E. R. and Cerottini, J. C. 1970. The function of macrophages
in the immune response. Seminars Hematol., ]_: 225-248.
Warner, N. L., Vaz, N. M. and Ovary, Z. 1968. Immunoglobulin classes
in antibody responses in mice. I. Analysis by biological
properties. Immunol. , 725-734.
Weigle, W. 0. and Fudenberg, H. H. 1966. Specificity of immunological
tolerance induced in the rabbit to genetic determinants of 
human yG globulin. Int. Arch. Allergy 28-35.
Weigle, W. 0. and Golub, E. S. 1967. Kinetics of the establishment of 
immunological unresponsiveness to serum protein antigens.
Cold Springs Harbor Symp. Quant. Biol., 555-558.
Weiner, J., Cottrell, J. S., Margaretten, W. and Spiro, D. 1967. An
electron microscopic study of steroid induced reticulo-endothe­
lial blockade. Amer. J. Path., 187-201.
Winer, B. J. 1962. Statistical Principles in Experimental Design. 
McCraw-Hill, New York. pp. 241-244.
Wooles, W. R. and DiLuzio, N. R. 1962. Influence of reticuloendothelial
hyperfunction on bone marrow transplantation. Amer. J.
Physiol., 203: 404-408.
Wooles, W. R. and DiLuzio, N. R. 1963. Reticuloendothelial function
and the immune response. Science 142: 1078-1080.
Wooles, W. R. and DiLuzio, N. R. 1964. Inhibition of homograft
acceptance and homo- and hetero-graft rejection in chimeras
by reticuloendothelial system stimulation. Proc. Soc. Exp.
Biol. Med., 1^: 756-759.
Wu, W. G. and Trice, K. L. 1967. Influence of cellular factors on 
immune unresponsiveness induced by Klebsiella penumoniae 
capsular antigen. J. Bact., 9̂ : 896-901.
Ziff, M. 1957. Serological Reactions of Rheumatoid Arthritis, Edited 
by R. W. Lamont-Havers, p. 31, Issued by The Arthritis and 
Rheumatism Foundation.
